CINXE.COM

<!DOCTYPE html><html lang="nl"><head><title>Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen"</title><meta http-equiv="X-UA-Compatible" content="IE=edge"/><meta charSet="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1.0,shrink-to-fit=no"/><meta name="apple-mobile-web-app-capable" content="yes"/><link rel="apple-touch-icon" sizes="180x180" href="/Themes/Corporate/ui/images/apple-touch-icon.png"/><link rel="icon" type="image/png" href="/Themes/Corporate/ui/images/favicon-32x32.png" sizes="32x32"/><link rel="icon" type="image/png" href="/Themes/Corporate/ui/images/favicon-16x16.png" sizes="16x16"/><link rel="manifest" href="/manifest.json"/><link rel="mask-icon" href="/Themes/Corporate/ui/images/safari-pinned-tab.svg" color="#666666"/><link rel="shortcut icon" href="/Themes/Corporate/ui/images/favicon.ico"/><meta name="apple-mobile-web-app-title" content="Takeda"/><meta name="application-name" content="Takeda"/><meta name="msapplication-config" content="/Themes/Corporate/ui/images/browserconfig.xml"/><meta name="theme-color" content="#ffffff"/><meta name="description" content="In de podcastserie "Onderweg naar Zorgen" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen in de ouderenzorg van 2040."/><meta name="robots" content="index,follow"/><meta property="og:title" content="Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen""/><meta property="og:description" content="In de podcastserie "Onderweg naar Zorgen" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen in de ouderenzorg van 2040."/><meta property="og:image" content="https://assets-dam.takeda.com/image/upload/v1675248866/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png"/><meta property="og:url" content="https://www.takeda.com/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen/"/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040"/><meta name="twitter:description" content="In de podcastserie "Onderweg naar Zorgen" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen in de ouderenzorg van 2040."/><meta name="twitter:image" content="https://assets-dam.takeda.com/image/upload/v1675248866/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png"/><meta name="twitter:url" content="https://www.takeda.com/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen/"/><meta name="twitter:widgets:csp" content="on"/><meta name="next-head-count" content="29"/><link rel="preload" href="/_next/static/media/3f90e6c778c79bff-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/83651bee47cf14da-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/6fed4e5749a3ea15-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/062522b8b7c3ad6a-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/e6f5886ae1242622-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/19e37deead9b3ec2-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/9beef36ab83de3f0-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/faac4ac11aa3d97b-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><link rel="preload" href="/_next/static/media/3d9ea938b6afa941-s.p.woff2" as="font" type="font/woff2" crossorigin="anonymous" data-next-font="size-adjust"/><script id="disable-nextjs-error-overlay-with-stackbit" data-nscript="beforeInteractive"> window.addEventListener('error', event => { if (undefined) { event.stopImmediatePropagation() } }) window.addEventListener('unhandledrejection', event => { if (undefined) { event.stopImmediatePropagation() } }) </script><link rel="preload" href="/_next/static/css/64c3be069bb1b5e7.css" as="style"/><link rel="stylesheet" href="/_next/static/css/64c3be069bb1b5e7.css" data-n-g=""/><link rel="preload" href="/_next/static/css/81d3d7d68e7efd5a.css" as="style"/><link rel="stylesheet" href="/_next/static/css/81d3d7d68e7efd5a.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="data:text/javascript,%20%20var%20_mtm%20%3D%20window._mtm%20%3D%20window._mtm%20%7C%7C%20%5B%5D%3B%0A%20%20_mtm.push%28%7B%27mtm.startTime%27%3A%20%28new%20Date%28%29.getTime%28%29%29%2C%20%27event%27%3A%20%27mtm.Start%27%7D%29%3B%0A%20%20%28function%28%29%20%7B%0A%20%20%20%20var%20d%3Ddocument%2C%20g%3Dd.createElement%28%27script%27%29%2C%20s%3Dd.getElementsByTagName%28%27script%27%29%5B0%5D%3B%0A%20%20%20%20g.async%3Dtrue%3B%20g.src%3D%27https%3A%2F%2Fcdn.matomo.cloud%2Ftakeda.matomo.cloud%2Fcontainer_rTZNKGIx.js%27%3B%20s.parentNode.insertBefore%28g%2Cs%29%3B%0A%20%20%7D%29%28%29%3B" _type="scriptTag" id="matomo-script" _key="b71b3c2c6d22" referrerPolicy="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/retail-investors-init.js" defer="" data-nscript="beforeInteractive"></script><script src="/Scripts/ipaddress_setting.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/jquery-2.1.1.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/jquery.validate-min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/vendors/jquery-ui/jquery-ui.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Scripts/bootstrap.min.js" defer="" data-nscript="beforeInteractive"></script><script src="/Themes/Corporate/ui/js/namespace.js" defer="" data-nscript="beforeInteractive"></script><script defer="" src="/_next/static/chunks/777.210bdb8857240742.js"></script><script defer="" src="/_next/static/chunks/3492.dbd61b12abfd0040.js"></script><script defer="" src="/_next/static/chunks/2062.6c841c37f71856ad.js"></script><script defer="" src="/_next/static/chunks/2516.c5e071a2082997f6.js"></script><script defer="" src="/_next/static/chunks/3896.cdce590d7942ed41.js"></script><script defer="" src="/_next/static/chunks/7597.f5d2dccbacb957c7.js"></script><script defer="" src="/_next/static/chunks/9391.0c91cf4d2d6ebf31.js"></script><script defer="" src="/_next/static/chunks/7322.25de4e8ed8b5c4f1.js"></script><script src="/_next/static/chunks/webpack-78b1e8dab864a455.js" defer=""></script><script src="/_next/static/chunks/framework-a09d748f2d67c977.js" defer=""></script><script src="/_next/static/chunks/main-b714e4244f8b51ae.js" defer=""></script><script src="/_next/static/chunks/pages/_app-d1f3c59f3f43461a.js" defer=""></script><script src="/_next/static/chunks/579-cc324184d2b9723f.js" defer=""></script><script src="/_next/static/chunks/1343-42765608927613e4.js" defer=""></script><script src="/_next/static/chunks/pages/%5B%5B...slug%5D%5D-35174e984ca0a2a2.js" defer=""></script><script src="/_next/static/zTwz2j3Sr5CveeDff3VTG/_buildManifest.js" defer=""></script><script src="/_next/static/zTwz2j3Sr5CveeDff3VTG/_ssgManifest.js" defer=""></script><style id="__jsx-4272609781">body{font-family:'__Open_Sans_cdfc58',sans-serif}</style></head><body itemscope="" itemType="http://schema.org/WebPage"><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="__next"><script id="OptanonWrapper" type="text/javascript">function OptanonWrapper() {}</script><div id="AccessibilitySection"><span><span class="Accessibility_hide-on-mobile accessibility-Text"><a href="#" class="UsableNetAssistive accessbility-Desktop-link">Toegankelijkheid inschakelen </a></span><span class="Accessibility_hide-on-desktop"><a href="#" class="UsableNetAssistive accessbility-mobile-link">Toegankelijkheid inschakelen </a></span></span><input type="hidden" id="disableAccessbility" value=""/></div><header class="main__header"><div class="main__header__top inner" itemscope="" itemType="http://schema.org/Organization"><a href="/nl-nl/" class="main__header__logo" accessKey="1" rel="noreferrer" data-watermark="watermark"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo" alt="HOME" class="main__header__logo__image" itemProp="logo"/><div class="main__header__tagline __className_141369"><span>Better Health,</span> <span class="main__header__tagline--break">Brighter Future</span></div></a><div class="main__header__nav"><nav class="nav-service" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/nl-nl/Jouw-gezondheid/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Jouw gezondheid</span></a><a href="/nl-nl/zorgverleners/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Zorgverleners</span></a><a href="/nl-nl/nieuws/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Nieuws</span></a><a href="/nl-nl/werken-bij/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Werken bij</span></a><a href="/nl-nl/Contact/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item">Contact</span></a><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/country-flags/nl" class="country__flag" alt=""/> <span>Nederland</span></a></div></nav></div></div><div id="wrapper-menu" class="menu__inner menu--dir-right"><input type="checkbox" class="state menu__toggle--mobile" aria-hidden="true" id="tgl-mobile"/><label for="tgl-mobile" class="menu__overlay--mobile"></label><label for="tgl-mobile" class="menu__toggle--mobile--wrapper"><span class="menu__toggle--mobile__icon"></span></label><div class="menu__wrapper"><nav class="menu" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/nl-nl/" class="main__header__logo" itemProp="url" rel="noreferrer" data-watermark="watermark"><img class="main__header__logo__image" sizes="100vw" alt="" loading="lazy" src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo"/></a><input id="item-0" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-0" class="menu__label " itemProp="name"><span class="menu__label__text">WIE WE ZIJN</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/nl-nl/wie-we-zijn/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Over Takeda</strong><span class="menu__panel__landing__caption"><div><span>Hoe kunnen we meer doen voor onze patiënten?<br>Alles bij Takeda begint met deze vraag.</span></div></span><span itemProp="name" class="menu__panel__link">Lees verder</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wie-we-zijn/informatie-over-ons-bedrijf/" rel="noreferrer" data-watermark="watermark"><div>Informatie over ons bedrijf</div></a></strong><a href="/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Geschiedenis</span></a><a href="/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Bedrijfsfeiten/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name"><div>Bedrijfsfeiten</div></span></a></div></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-0" type="button"><span class="close-menu"> </span></button></div><input id="item-1" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-1" class="menu__label " itemProp="name"><span class="menu__label__text">WAT WE DOEN</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/nl-nl/wat-we-doen/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Ons werkveld</strong><span class="menu__panel__landing__caption"><div>Takeda zet zijn transformatie voort naar een agile en innovatieve wereldwijde farmaceutische leider, die tegemoetkomt aan de behoeften van patiënten en artsen wereldwijd.</div></span><span itemProp="name" class="menu__panel__link">Lees verder</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wat-we-doen/patient-centraal/" rel="noreferrer" data-watermark="watermark">Patiënt centraal</a></strong><a href="/nl-nl/wat-we-doen/patient-centraal/samenwerking-met-patientenorganisaties/" class="menu__panel__submenu__link" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Samenwerking met patiëntenorganisaties</span></a></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wat-we-doen/therapeutische-gebieden/" rel="noreferrer" data-watermark="watermark">Therapeutische gebieden</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wat-we-doen/geneesmiddelen/" rel="noreferrer" data-watermark="watermark">Geneesmiddelen</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wat-we-doen/research-and-development/" rel="noreferrer" data-watermark="watermark">Research & Development</a></strong></div><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/wat-we-doen/verzoek-om-sponsoring/" rel="noreferrer" data-watermark="watermark">Verzoek om Sponsoring</a></strong></div></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-1" type="button"><span class="close-menu"> </span></button></div><input id="item-2" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-2" class="menu__label " itemProp="name"><span class="menu__label__text">Onze verhalen</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/nl-nl/Onze-verhalen/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Onze verhalen</strong><span class="menu__panel__landing__caption"><div>Ontdek de verhalen van Takeda over innovatie, zorg en ons erfgoed</div></span><span itemProp="name" class="menu__panel__link">Lees verder</span></a></div><div class="menu__sub__expanded"></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-2" type="button"><span class="close-menu"> </span></button></div><input id="item-3" name="mega" type="radio" class="state" aria-hidden="true"/><label for="item-3" class="menu__label " itemProp="name"><span class="menu__label__text">Maatschappelijk ondernemen</span></label><div class="menu__panel"><div class="menu__panel__inner"><div class="menu__sub"><a href="/nl-nl/maatschappelijk-ondernemen/" itemProp="url" rel="noreferrer" data-watermark="watermark"><strong class="menu__sub__heading">Takeda's CSR</strong><span class="menu__panel__landing__caption"><div>Takeda hecht veel waarde aan Maatschappelijk Verantwoord Ondernemen (MVO). De inzet voor MVO is verweven in onze bedrijfsstrategie en dagelijkse praktijken.</div></span><span itemProp="name" class="menu__panel__link">Lees verder</span></a></div><div class="menu__sub__expanded"><div class="menu__panel__inner__content"><strong class="menu__sub__heading"><a href="/nl-nl/maatschappelijk-ondernemen/maatschappelijk-verantwoord-ondernemen/" rel="noreferrer" data-watermark="watermark">Maatschappelijk verantwoord ondernemen</a></strong></div></div><div class="menu__sub menu__panel__feature"></div></div><button id="btnClose-3" type="button"><span class="close-menu"> </span></button></div><nav class="styles_navMobile__dVKw_" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/nl-nl/Jouw-gezondheid/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.0" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Jouw gezondheid</span></a><a href="/nl-nl/zorgverleners/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.1" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Zorgverleners</span></a><a href="/nl-nl/nieuws/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.2" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Nieuws</span></a><a href="/nl-nl/werken-bij/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.3" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Werken bij</span></a><a href="/nl-nl/Contact/" data-is-active="false" aria-current="false" class="nav-service__url" itemProp="url" data-sb-field-path=".topToolbarLinksCollection.4" rel="noreferrer" data-watermark="watermark"> <span itemProp="name" class="nav-service__url--item" data-sb-field-path=".title .text">Contact</span></a><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/country-flags/nl" class="country__flag" alt=""/> <span>Nederland</span></a></div></nav><input id="tgl-overlay" name="mega" type="radio" class="state menu__toggle" aria-hidden="true" checked=""/><label for="tgl-overlay" class="menu__overlay"></label><form itemscope="" itemType="http://schema.org/WebSite" class="search whitespace-nowrap"><div itemProp="potentialAction" itemscope="" itemType="http://schema.org/SearchAction" class="search__fieldset"><meta itemProp="target"/><label for="search-submit"><button type="submit" id="search-submit" class="search__submit" title="Search"><svg class="search__submit__image"><use xlink:href="/Themes/Shared/ui/svg/takeda.svg#icon-search"></use></svg></button> </label><label><input id="query" name="query" type="text" placeholder="Zoeken" class="search__input" itemProp="query-input" autoComplete="off" value=""/></label></div></form></nav></div></div><input type="checkbox" class="state" aria-hidden="true" id="tgl-search"/><label for="tgl-search" class="search__toggle"><svg class="search__toggle__icon"><use xlink:href="/Themes/Shared/ui/svg/takeda.svg#icon-search"></use></svg></label><div class="search__mobile"><form><label><label><input id="search-input-mobile" name="query" type="text" placeholder="Zoeken" class="search__input" itemProp="query-input" autoComplete="off" value=""/></label></label></form></div></header><main class="main inner"><nav class="breadcrumb-social__wrapper"><div class="breadcrumbs" itemProp="breadcrumb" itemscope="" itemType="http://schema.org/BreadcrumbList"><span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="4"/><a class="item" href="/nl-nl/" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">HOME</span></a></span> <span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="3"/><a class="item" href="/nl-nl/nieuws/" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">Nieuws</span></a></span> <span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="2"/><a class="item" href="/nl-nl/nieuws/Persberichten/" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">Nieuwsberichten</span></a></span> <span itemProp="itemListElement" itemscope="" itemType="http://schema.org/ListItem"><meta itemProp="position" content="1"/><span class="active" itemscope="" itemType="http://schema.org/Thing" itemProp="item"><span itemProp="name">Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040</span><meta itemProp="url" content="/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen"/></span></span> </div><nav class="social-sharing" itemscope="" itemType="http://schema.org/SiteNavigationElement"><span class="social-sharing__text">Delen:</span><span class="social-sharing__icons"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fbit.ly%2F45UUAfc" title="facebook" target="_blank" rel="noreferrer"><span class="icon" data-action="facebook"><meta itemProp="name" content="facebook"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-facebook"></use></svg></span></a> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fbit.ly%2F45UUAfc&title=Takeda%20lanceert%20nieuwe%20podcastserie%20%E2%80%9COnderweg%20naar%20zorgen%E2%80%9D%20en%20duikt%20in%20de%20toekomst%20van%20ouderenzorg%20in%20Nederland%20in%202040&summary=&source=" title="linkedin" target="_blank" rel="noreferrer"><span class="icon" data-action="linkedin"><meta itemProp="name" content="linkedin"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-linkedin"></use></svg></span></a> <a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fbit.ly%2F45UUAfc&text=Takeda%20lanceert%20nieuwe%20podcastserie%20%E2%80%9COnderweg%20naar%20zorgen%E2%80%9D%20en%20duikt%20in%20de%20toekomst%20van%20ouderenzorg%20in%20Nederland%20in%202040" title="twitter" target="_blank" rel="noreferrer"><span class="icon" data-action="twitter"><meta itemProp="name" content="twitter"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-twitter"></use></svg></span></a> <a href="/cdn-cgi/l/email-protection#112e6264737b7472652c587a34232166787d34232175786534232176637070763423217c74653423217b7434232175747d747f3f37707c612a737e75682c56637e7465747f342352342150342150587a342321677e7f75342321757865342321787f657463746262707f65342321747f342321787a3423216b7e6434232179746534232176637070763423217c74653423217b7434232166787d7d747f34232175747d747f3f3421503421503145707a7475703423217d707f72747463653423217f7874646674342321617e757270626562746378743423213454233429213428525e7f7574636674763423217f7070633423216b7e6376747f345423342921342855342321747f3423217564787a65342321787f3423217574342321657e747a7e7c626534232167707f3423217e64757463747f6b7e6376342321787f3423215f747574637d707f75342321787f342321232125213179656561623422503423573423577378653f7d6834235725244444507772" title="email" target="_blank" rel="noreferrer"><span class="icon" data-action="email"><meta itemProp="name" content="email"/><svg class="circle-icon"><use href="/Resources/ui/svg/takeda.svg#icon-email"></use></svg></span></a></span></nav></nav><section class="flex-row"><div class="grid-1-4"><nav class="secondary" itemscope="" itemType="http://schema.org/SiteNavigationElement"><input class="lg:block" type="checkbox" id="secondary__toggle--nav"/><label class="lg:!block" for="secondary__toggle--nav" data-js="animateHeight"><span class="secondary__heading" itemProp="name" data-href="/nl-nl/nieuws/">Nieuws</span></label><div class="secondary__dropdown"><div class="secondary__dropdown__content"><a href="/nl-nl/nieuws/Persberichten/" class="secondary__link secondary__link--current" rel="noreferrer" data-watermark="watermark"><span>Nieuwsberichten</span></a></div></div></nav></div><div class="grid-3-4"><div class="grid-1-1"><div class="heading"><a href="https://www.takeda.com/system/news-releases-rss/" class="news__rss"><svg class="news__rss-icon"><use href="/Themes/Shared/ui/svg/takeda.svg#icon-rss"></use></svg></a><header class="news__header"><h1><div>Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040.</div></h1><div class="news__header__info"><span class="news__header__info--date news__header__info--divider">5 september 2023</span></div></header></div><div class="introduction"></div><div class="mainBody"><p><strong>Hoofddorp, 5 september 2023. De zorg voor ouderen stevent af op grote uitdagingen. In 2040 zullen we maar liefst 4,9 miljoen inwoners van 65 jaar en ouder tellen. Concreet betekent dit dat een kwart van de totale Nederlandse bevolking als ‘oudere’ wordt aangemerkt. Deze aanzienlijke groep zal extra zorg en ondersteuning nodig hebben, terwijl het aantal mensen in de werkzame leeftijd juist afneemt. In de podcastserie "Onderweg naar Zorgen" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen om uiteindelijk advies te kunnen geven over hoe we met meer vertrouwen naar de toekomst kunnen kijken. Alle afleveringen zijn vanaf nu te beluisteren via diverse podcast apps.</strong></p> <p>De zoektocht naar mogelijke oplossingen voor de toekomstige problematiek in de ouderenzorg is een reis die niet alleen de huidige uitdagingen belicht, maar ook een licht werpt op de mogelijkheden die voor ons liggen. De serie behandelt een breed scala aan thema’s zoals de rol van technologie, kunstmatige intelligentie en innovatieve burgerinitiatieven in de ouderenzorg. </p></div><div class="epi-wrapper"><div class="grid-2-3"><div style="display:block;position:relative"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;padding-top:75%"></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url("data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAICAMAAAD3JJ6EAAAAhFBMVEVgjX1lfHJPb2BlmIZkkYBVSUISFhRhkoQ5NzJDZFh6iHpMRTxihXQwOT1zpZJPVFdJPjNTe3OMWk9oWEohIR6dZF4nMj1Zi36JfW9Uh3yklJRhZlyVfXJBV0taRDlUcmkoMy5TbHWJiYaLeoZpb19bU1CRep5pXEhwbHq9gnWki3HJnovF+lVOAAAAVElEQVQIHQXBhwKAEAAFwEeEUmjvtNf//193EEIwBpamAdoagkHPi4JbI0APKlFw50aipiOegtzHHsemlwrUeBqGnMsRb26vosi5TPA9ZZllk5XVD74iBPfNeUBxAAAAAElFTkSuQmCC")"/><noscript><img alt="" loading="lazy" decoding="async" data-nimg="responsive" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" sizes="(max-width: 768px) 100vw, 67vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_750/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 750w, https://assets-dam.takeda.com/image/upload/c_lfill,w_828/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 828w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 1920w, https://assets-dam.takeda.com/image/upload/c_lfill,w_2048/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 2048w, https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ 3840w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ"/></noscript></span></div></div><div class=""><div><div class="richtext"><p>Paul en Aarnoud benaderen de thematiek in de podcastserie met een combinatie van realisme en optimisme. Ze bespreken de knelpunten en zoeken naar haalbare oplossingen voor wat zij als een "stille crisis" zien. Ze beschrijven zichzelf als "twee vakidioten, werkzaam bij een innovatief farmaceutisch bedrijf", waar ze talloze gesprekken voerden over de toekomst van de zorg, elk vanuit hun eigen perspectief. Met een diepgewortelde overtuiging dat er verandering nodig is in de zorg, vragen ze zich af waarom veranderingen in de ouderenzorg zo traag gaan. Ze willen de ‘stille crisis’ op de kaart zetten en de maatschappelijke steun voor (het zoeken naar) oplossingen vergroten. Pauls focus ligt op de toegankelijkheid van de zorg voor iedereen, terwijl Aarnoud gefascineerd is door de manier waarop Nederlanders ouder worden en welke rol technologie daarin kan spelen.</p> <p>De huidige podcastserie bestaat uit 4 afleveringen, waarin ze de luisteraar meenemen op onderzoek in 'het Lab', vervolgens gaan ze door naar 'de Spreekkamer’ waar ze in gesprek gaan met de hoofdgast, een expert uit het zorgveld. Ze sluiten dit gesprek af met het 'Recept' voor een betere ouderenzorg. Paul en Aarnoud sluiten elke aflevering af met hun aanbeveling voor de toekomst. Wil je meer informatie over deze podcastserie? Ga dan naar: <a href="www.stemvandepatient.nl">www.stemvandepatient.nl</a></p> <p>Deze podcast is gemaakt door Takeda Nederland. Als innovatief gezondheidsbedrijf heeft Takeda aandacht voor belangrijke ontwikkelingen in de zorg. Takeda is een wereldwijd, op waarden gebaseerd, R&D-gedreven biofarmaceutisch bedrijf. Ons hoofdkantoor staat in Japan. Wij zetten ons sinds 1781 in voor het ontdekken en leveren van levensveranderende behandelingen om patiënten te genezen of hun kwaliteit van leven te verbeteren. Daarbij laten we ons leiden door onze toewijding aan patiënten, onze mensen en de planeet. In Nederland zijn we actief sinds de jaren ‘50. Takeda richt zijn R&D-inspanningen op vier therapeutische gebieden: oncologie-hematologie, zeldzame genetische ziekten, neurowetenschappen en gastro-enterologie (GI). We doen ook gerichte R&D-investeringen in van plasma afgeleide therapieën en vaccins (<a href="www.takeda.nl">www.takeda.nl</a>).</p></div></div></div></div></div></div><div></div></section></main><nav class="totop__wrapper" itemscope="" itemType="http://schema.org/SiteNavigationElement"><div class="totop__inner"><div class="totop" itemProp="name">TOP</div></div></nav><footer class="footer"><div class="footer__content"><div class="footer__nav" itemscope="" itemType="http://schema.org/SiteNavigationElement"><a href="/terms-of-use/?epslanguage=en" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">GEBRUIKSVOORWAARDEN</span></a><a href="/nl-nl/privacyverklaring/?epslanguage=nl-NL" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Privacyverklaring</span></a><a href="/accessibility-statement/?lang=nl" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Toegankelijkheidsverklaring</span></a><a href="/cookie-policy/" class="footer__url" itemProp="url" rel="noreferrer" data-watermark="watermark"><span itemProp="name">Cookie Policy</span></a><div class="footer__copyright--desktop"><div>Copyright 1995-2025 Takeda Pharmaceutical Company Limited. All rights reserved.<br><br>C-ANPROM/NL/GEN/0045-NOV 2023</div></div></div><div class="footer__social-wrap"><div class="footer__social"><div class="footer__social__text">Verbind je met ons:</div> <div class="footer__social__links"><a href="https://www.linkedin.com/company/takeda-pharmaceuticals/" title="linkedin" target="_blank" rel="noreferrer"><span class="icon" data-action="linkedin"><meta itemProp="name" content="linkedin"/><svg class="footer__social__icon icon--social"><use href="/Resources/ui/svg/takeda.svg#icon-linkedin"></use></svg></span></a> <a href="http://www.twitter.com/takedapharma" title="twitter" target="_blank" rel="noreferrer"><span class="icon" data-action="twitter"><meta itemProp="name" content="twitter"/><svg class="footer__social__icon icon--social"><use href="/Resources/ui/svg/takeda.svg#icon-twitter"></use></svg></span></a> </div></div><div class="footer__worlwide"><div class=""><a href="/worldwide/" class="countryselector__url"><img src="https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/country-flags/nl" class="country__flag" alt=""/> <span>Nederland</span></a></div><div class=""><div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script> (function() { var pageLanguage = document.getElementsByTagName('html')[0].getAttribute('lang'); if (pageLanguage != null) { var match = pageLanguage.match(/ja|ja-JP|ko|kok|kok-IN|ko-KP|ko-KR|km|km-KH|kn|kn-IN|zh|zh-CHS|zh-CHT|zh-CN|zh-Hans|zh-Hans-HK|zh-Hans-MO|zh-Hant|zh-HK|zh-MO|zh-SG|zh-TW|zgh|zgh-Tfng|zgh-Tfng-MA/g); if (!document.querySelector("#tinymce") && match == null) { var aSpans = document.querySelectorAll('.custom-shy'), nSpans = aSpans.length; for (i = 0; i < nSpans; i++) aSpans[i].outerHTML = ''; } } var tempDiv = document.createElement('div'); tempDiv.setAttribute("id", "tinymce"); document.body.appendChild(tempDiv); })(); </script></div></div></div></div></div></footer><div><div class="footer__copyright--mobile"><div>Copyright 1995-2025 Takeda Pharmaceutical Company Limited. All rights reserved.<br><br>C-ANPROM/NL/GEN/0045-NOV 2023</div></div></div><div class="footer__settings"><div class=""></div><div class=""><div><div class="richtext"></div></div></div></div><div id="ir-subscription-wrapper" class="modal fade" tabindex="-1" role="dialog" aria-hidden="true"><div class="modal-dialog modal-lg modal-dialog-centered"><div class="modal-content"></div><a class="close-modal" data-dismiss="modal" aria-label="Close">Close</a></div></div><link rel="stylesheet" href="/Themes/Corporate/ui/css/vendors/jquery-ui/jquery-ui.min.css" class="jsx-4272609781"/></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"homepage":{"mainHeroArea":[{"customCssClass":"","callToActionLinkText":"LEES VERDER","_type":"heroBannerBlock","backgroundImageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"92a5030d-e818-43a7-88e1-a667353def2d","url":{"_key":"65d9919b-7cb4-4858-9e77-f0dd132c19c1","_type":"cloudinary.asset","height":395,"format":"jpg","resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1670162850/legacy-dotcom/siteassets/nl-nl/home/a-streamer-homepage.jpg","created_at":"2022-09-09T10:43:27Z","url":"http://assets-dam.takeda.com/image/upload/v1670162850/legacy-dotcom/siteassets/nl-nl/home/a-streamer-homepage.jpg","public_id":"legacy-dotcom/siteassets/nl-nl/home/a-streamer-homepage","type":"upload","width":1600,"bytes":360336,"_version":1,"version":1670162850}},"spotContentAsString":"\u003cp\u003e\u003cstrong\u003eDe pati\u0026euml;nt centraal\u003cbr /\u003e\u003c/strong\u003eHet ultieme doel van Takeda is dat pati\u0026euml;nten beter worden of zich beter voelen. Met onze geneesmiddelen - en de zoektocht naar nieuwe - willen we pati\u0026euml;nten hierbij ondersteunen.\u003c/p\u003e","_key":"330624b1-46d4-4213-8d0b-16dfe89989ac","displayOption":"full","backgroundImageAlignment":0,"spotContentAlignment":0,"callToActionLinkUrl":"/nl-nl/wat-we-doen/patient-centraal/"}],"contentFolderWasParent":true,"hideSocialSharingButtons":true,"_id":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"215fd4d2-9d1e-4f45-996d-af39e8178571"},"releaseDate":"2018-01-11T07:29:37.473+00:00","optimizelyId":"888","seo":{"_type":"seoBlock","title":"Takeda Netherlands","openGraphTitle":"Takeda Netherlands","targetGroup":0,"_key":"138b6f5b-f117-47f4-9770-dabaf3f3d922","openGraphImage":"","indexing":0,"openGraphDescription":"Learn more about Takeda in the Netherlands","descriptionString":"Learn more about Takeda in the Netherlands"},"partialPageCallToActionText":"Learn more","_createdAt":"2017-10-26T15:40:30Z","partialPageThumbnailAlt":"","hideFooter":false,"canonicalUrl":"https://www.takeda.com/","_langRefs":null,"settingsPage":{"_weak":true,"_ref":"f6caa076-f145-407f-b409-1b3e38b0e08a","_type":"reference"},"_updatedAt":"2025-01-15T18:26:28Z","mainContentArea":[{"link":"/nl-nl/wat-we-doen/verzoek-om-sponsoring/","customCssClass":"","linkStyling":"normal","_type":"spotBlock","headingAsString":"Verzoek om Sponsoring\n","backgroundColor":"","headingColor":"color1","_key":"bfd80c63-4015-4dea-8591-272fc33fb047","displayOption":"half","image":{"_type":"imageFile","_key":"9fbf3670-30a0-4255-9461-8b0596ce075e","url":{"type":"upload","public_id":"legacy-dotcom/siteassets/nl-nl/home/what-we-do/innovatie/innovatie---block","format":"jpg","width":1600,"height":900,"created_at":"2022-09-09T10:43:31Z","url":"http://assets-dam.takeda.com/image/upload/v1671445591/legacy-dotcom/siteassets/nl-nl/home/what-we-do/innovatie/innovatie---block.jpg","resource_type":"image","version":1671445591,"bytes":830586,"_version":1,"_key":"8039991c-5d28-4ff2-ad92-3a81331f676d","_type":"cloudinary.asset","secure_url":"https://assets-dam.takeda.com/image/upload/v1671445591/legacy-dotcom/siteassets/nl-nl/home/what-we-do/innovatie/innovatie---block.jpg"},"excludeFromSearch":false},"linkText":"LEES VERDER","linkCasing":"normal","layout":"topimage"},{"headingColor":"color1","customCssClass":"","layout":"topimage","linkText":"LEES VERDER","linkCasing":"normal","backgroundColor":"","_type":"spotBlock","link":"/nl-nl/wat-we-doen/geneesmiddelen/","linkStyling":"normal","_key":"54fd2743-734d-47ec-9988-569df74d2f96","displayOption":"half","headingAsString":"Onze geneesmiddelen","image":{"excludeFromSearch":false,"_type":"imageFile","_key":"b297ca2b-bff7-43ce-954d-4f9be8426a52","url":{"type":"upload","_version":1,"public_id":"legacy-dotcom/siteassets/nl-nl/home/what-we-do/geneesmiddelen/geneesmiddelen---block","width":1600,"height":900,"bytes":726857,"version":1671438590,"url":"http://assets-dam.takeda.com/image/upload/v1671438590/legacy-dotcom/siteassets/nl-nl/home/what-we-do/geneesmiddelen/geneesmiddelen---block.jpg","created_at":"2022-09-09T10:43:32Z","_type":"cloudinary.asset","resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1671438590/legacy-dotcom/siteassets/nl-nl/home/what-we-do/geneesmiddelen/geneesmiddelen---block.jpg","format":"jpg","_key":"4f6ebff4-d25d-4e9e-a4bf-5207ae967a23"}}},{"tab3Heading":"","tab1Title":"RECENT NIEUWS","tab3BackgroundColor":"color4","tab1BackgroundColor":"color4","_key":"1394f4c1-6f50-4b43-9ae6-d7dd17db37ff","displayOption":"full","tab1Heading":"","tab2Heading":"","tab1Content":[{"sortOrder":1,"loadMoreButtonText":"GO TO THE NEWSROOM","backgroundColor":"Color4","dontRenderItemLinks":false,"linkText":"","pageTypeIds":"68","layout":"simple","_key":"a51ad5b6-704e-4676-976b-5e5d21f624b4","categoryMatchMode":1,"displayOption":"","allTopicsLabel":"","root":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","_type":"reference"},"hideLoadMoreButton":true,"_type":"filteredListSpotBlock","hideTopicsFilter":false,"itemsToTake":5,"linkStyling":"","dateFormat":"","linkCasing":"","noContentMessage":"","headingColor":""},{"_key":"bb383673-5b23-49ed-9b0a-3fb4ddec7aff","displayOption":"full","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":"\u003cp style=\"text-align: left;\"\u003e\u003ca href=\"/nl-nl/nieuws/Persberichten/\"\u003e\u003cstrong\u003eMEER NIEUWS \u0026gt;\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e","_type":"richTextBlock"}],"tab2BackgroundColor":"color4","tab2Title":"","customCssClass":"","tab3Title":"","_type":"tabContainerBlock"},{"backgroundColor":"color1","linkCasing":"normal","_key":"d8c76484-607f-4836-b526-d7639e22e2e2","linkStyling":"bold","_type":"spotBlock","linkText":"","displayOption":"onethird","headingColor":"color1","contentAsString":"\u0026nbsp;","customCssClass":"","headingAsString":"\u0026nbsp;","layout":"topimage"}],"parentWasSkipped":false,"sortIndex":100,"theme":"corporate","shortUrl":"https://takeda.info/3ftiVOR","_type":"sectionPage","trackingRoot":false,"excludeFromSearch":false,"linkType":"normal","friendlyUrl":{"current":"/nl-nl/","_type":"slug","_key":"6cd6d6e2-563b-4504-bc2f-ec8e7fe5e837"},"_base":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094","_type":"reference"},"customCssClass":"","parent":{"_ref":"e2cbba90-4d9e-4b44-80ef-114f703b6375","_type":"reference","_weak":true},"childSortOrder":"index","startPublish":"2018-01-11T07:29:37.473+00:00","visibleInMenu":true,"showNewInLanguages":"","_rev":"je0GYv48ymjXkiePSFFJrV","hideInThisSection":false,"language":"nl-NL","title":"HOME","partialPageHeading":"","hideBreadCrumb":true,"hideHeader":false,"urlSegment":"/nl-nl/"},"siteSettings":{"_createdAt":"2017-10-26T15:41:32Z","startPublish":"2018-01-11T07:30:44.13+00:00","useCustomCdnExpiration":false,"parentWasSkipped":false,"parent":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","_type":"reference"},"title":"Settings - nl-NL","urlSegment":"/nl-nl/system/settings/","useImageWarningMessage":false,"_id":"f6caa076-f145-407f-b409-1b3e38b0e08a__i18n_nl-NL","releaseDate":"2018-01-11T07:30:44.13+00:00","language":"nl-NL","sortIndex":0,"_type":"siteSettingsPage","seo":{"_key":"b8d306e7-d0c9-4d59-98d8-07182ffda6c6","openGraphImage":"","targetGroup":0,"indexing":0,"_type":"seoBlock"},"useNotoSansSc":false,"cdnExpiration":0,"showNewInLanguages":"","layoutSettings":[{"topTaglineDesktopLabel":"Better Health, Brighter Future","enableAccessibilityText":"Toegankelijkheid inschakelen ","seoOrganizationData":{"_type":"seoOrganizationBlock","_key":"edc959f2-c7c9-4da1-a215-a1428e2891ec","items":[{"_type":"keyValueListItem","_key":"9590dc3e-2fed-49bd-bdac-88258ae3ea69","value":"Takeda Pharmaceutical Company Limited","key":"name"},{"_type":"keyValueListItem","_key":"1284cd97-807c-4a40-af97-a509bd615c16","value":"http://www.takeda.com","key":"url"},{"_key":"adc6f59f-5a37-400d-9f07-c27fc125c871","value":"https://www.linkedin.com/company/5482","key":"sameAs","_type":"keyValueListItem"}]},"_key":"96eb2abe-81ba-4951-9456-262229114f8d","topTaglineMobileLabelLine1":"Better Health,","topToolbarLinksCollection":[{"_type":"linkItem","href":"/nl-nl/Jouw-gezondheid/","text":"Jouw gezondheid","_key":"b23058ae-10fe-4d64-b2b6-6695ca1fbc76"},{"_type":"linkItem","href":"/nl-nl/zorgverleners/","text":"Zorgverleners","_key":"1d9788ee-034f-4d77-b7d5-b854cee48586"},{"_type":"linkItem","href":"/nl-nl/nieuws/","text":"Nieuws","_key":"87e4f4d3-8051-48f3-9b7a-041ce1068276"},{"_type":"linkItem","href":"/nl-nl/werken-bij/","text":"Werken bij","_key":"133a72a1-4fa0-4b01-92c0-935106ed4f80"},{"_type":"linkItem","href":"/nl-nl/Contact/","text":"Contact","_key":"baa9c506-4a11-41ec-8fcc-5bfef2752c5c"}],"topTaglineMobileLabelLine2":"Brighter Future","logoUrl":{"url":{"bytes":3685,"url":"http://assets-dam.takeda.com/image/upload/v1662720236/legacy-dotcom/globalassets/corporate/takeda_logo.svg","height":599,"type":"upload","created_at":"2022-09-09T10:43:56Z","version":1662720236,"secure_url":"https://assets-dam.takeda.com/image/upload/v1662720236/legacy-dotcom/globalassets/corporate/takeda_logo.svg","_key":"de2920e7-3fb5-4fc6-8103-2be8fae2a042","public_id":"legacy-dotcom/globalassets/corporate/takeda_logo","width":1080,"_version":1,"_type":"cloudinary.asset","resource_type":"image","format":"svg"},"excludeFromSearch":false,"_type":"imageFile","_key":"a75784ee-39c9-4fb2-8845-9bbabf8d1b23","blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGBAMAAAAI3hL1AAAAKlBMVEVHcEz50tP0r7L+9/f4ztDwj5L3x8n3x8jyoKPxmp31t7n0rrD+8vL2vb9BuiRAAAAAC3RSTlMAEUgBHWQ96+jn7CJFrYQAAAAiSURBVAjXY2CAAMY0AQYG5qgzpQYMLL27dzowMAgpKULlAFZoBOAQ1TjWAAAAAElFTkSuQmCC"},"disableAccessibilityText":"","_type":"headerBlock","topToolbarLinksContent":[{"flagUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"0d2da993-76d1-4b6f-80aa-f7ac40660934","url":{"_version":1,"created_at":"2022-09-09T10:45:49Z","type":"upload","_type":"cloudinary.asset","width":900,"resource_type":"image","public_id":"legacy-dotcom/globalassets/country-flags/nl","bytes":518,"secure_url":"https://assets-dam.takeda.com/image/upload/v1670931340/legacy-dotcom/globalassets/country-flags/nl.png","_key":"3eea6f2c-7e67-4734-b69c-6c7c441fe2b8","format":"png","height":600,"version":1670931340,"url":"http://assets-dam.takeda.com/image/upload/v1670931340/legacy-dotcom/globalassets/country-flags/nl.png"},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHBAMAAADDgsFQAAAAD1BMVEW1wdjks7chRouuHCj///+gCMgLAAAAGklEQVQI12MwBgEGCCkIAgwuIMAAAUogACEBdLUE/MUBSE4AAAAASUVORK5CYII="},"_type":"countrySelectorLinkBlock","link":"/worldwide/","linkText":"Nederland","_key":"b7c870db-143d-4e8b-a5f2-5d62ddf5da13"}],"logoTargetUrl":"/nl-nl/"},{"_type":"menuBlock","_key":"a17b1b4a-2729-4fbb-b513-6e76f9e2eb4c","menu":[{"submenu":[{"_type":"menuItem","_key":"fd79ef00-135e-4c72-ba92-48f0e9a109c3","submenu":[{"_type":"menuItem","_key":"e2abd2ca-a6d8-4657-a26a-2e87c681f3c4","submenu":null,"document":{"_id":"6716cb7f-dcea-41c4-948d-a3d51484e782__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Bedrijfsfeiten/","_type":"slug","_key":"c464e1af-49e4-423d-8682-412cb6ccd8a3"},"navigationNameAsString":"\u003cdiv\u003eBedrijfsfeiten\u003c/div\u003e","title":"Bedrijfsfeiten"}},{"_type":"menuItem","_key":"671f6ebf-9391-465c-9f3c-ed3970888517","submenu":null,"document":{"_id":"db175be3-8e1c-4c2e-8d69-bad25ca4d823__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/","_type":"slug","_key":"8da665ee-c246-415f-90ed-e7e4e61a0951"},"navigationNameAsString":"","title":"Geschiedenis"}}],"document":null},{"_key":"39d66417-a9f2-4115-82ee-61bd463967be","submenu":[{"submenu":null,"document":{"_id":"db175be3-8e1c-4c2e-8d69-bad25ca4d823__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/","_type":"slug","_key":"8da665ee-c246-415f-90ed-e7e4e61a0951"},"navigationNameAsString":"","title":"Geschiedenis"},"_type":"menuItem","_key":"7dccaf0d-13ca-410e-bb38-ec0d271f3297"},{"document":{"_id":"6716cb7f-dcea-41c4-948d-a3d51484e782__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Bedrijfsfeiten/","_type":"slug","_key":"c464e1af-49e4-423d-8682-412cb6ccd8a3"},"navigationNameAsString":"\u003cdiv\u003eBedrijfsfeiten\u003c/div\u003e","title":"Bedrijfsfeiten"},"_type":"menuItem","_key":"ef8ec178650807ea37da88e804c027e2","submenu":null}],"document":{"_id":"fb86d2a1-7253-4e8c-a589-27273b764fc8","friendlyUrl":{"current":"/nl-nl/wie-we-zijn/informatie-over-ons-bedrijf/","_type":"slug"},"navigationNameAsString":"\u003cdiv\u003eInformatie over ons bedrijf\u003c/div\u003e","title":"Informatie over ons bedrijf"},"_type":"menuItem"},{"document":null,"_type":"menuItem","_key":"02ddd632-f9b6-4c50-b673-1110fd8cbef8","submenu":[]}],"document":{"partialPageCallToActionLink":null,"partialPageHeading":"Over Takeda","partialPageIntroAsString":"\u003cdiv\u003e\u003cspan\u003eHoe kunnen we meer doen voor onze patiënten?\u003cbr\u003eAlles bij Takeda begint met deze vraag.\u003c/span\u003e\u003c/div\u003e","featuredContent":null,"friendlyUrl":{"current":"/nl-nl/wie-we-zijn/","_type":"slug","_key":"b1fc6036-0e13-451f-b8b9-806ea889e7bf"},"title":"WIE WE ZIJN","partialPageCallToActionText":"Lees verder","_id":"7d6ac569-14f6-48e3-bb00-eee484816321__i18n_nl-NL","navigationNameAsString":""},"_type":"menuItem","_key":"82ede243-5be1-4ee7-ae61-84e9e35c685c"},{"_key":"80cbdace-6f10-4188-a736-7115536030fe","submenu":[{"submenu":[{"submenu":null,"document":{"_id":"20e40f22-10c4-4b44-945d-c5bbbb7f491b","friendlyUrl":{"current":"/nl-nl/wat-we-doen/patient-centraal/samenwerking-met-patientenorganisaties/","_type":"slug","_key":"5bed9e40-6cdf-43e6-8275-a3debf99b0fe"},"navigationNameAsString":"","title":"Samenwerking met patiëntenorganisaties"},"_type":"menuItem","_key":"597c7c7f-ddeb-46e1-9623-4e7e5b010937"}],"document":{"_id":"d6d34fc7-ef65-4630-af2e-9608ceb6035d","friendlyUrl":{"current":"/nl-nl/wat-we-doen/patient-centraal/","_type":"slug","_key":"0c84b8ce-2225-48a0-ae37-02c526d9694b"},"navigationNameAsString":"","title":"Patiënt centraal"},"_type":"menuItem","_key":"369983ce-8c09-4da3-a3bd-b313be86bb64"},{"document":{"_id":"d2cd6703-ef33-4312-b6c9-dc41dc05ffb2","friendlyUrl":{"current":"/nl-nl/wat-we-doen/therapeutische-gebieden/","_type":"slug","_key":"e602311f-7ff1-4d07-94f4-15cf1aa63abc"},"navigationNameAsString":"","title":"Therapeutische gebieden"},"_type":"menuItem","_key":"80e44171-d4eb-423e-bd82-adafb629e627","submenu":[]},{"submenu":[],"document":{"_id":"811c6ed6-47a1-4fe3-b843-a1fdbb047447","friendlyUrl":{"current":"/nl-nl/wat-we-doen/geneesmiddelen/","_type":"slug","_key":"6b7ccb90-0942-4f08-beca-406ca10c9012"},"navigationNameAsString":"","title":"Geneesmiddelen"},"_type":"menuItem","_key":"b23ff759-698b-45de-9c17-910f592e6110"},{"_key":"e15a370260a489ae08ec49129e0a963f","submenu":[],"document":{"_id":"3a16aa73-0620-421d-a55b-7fd984118f21__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/wat-we-doen/research-and-development/","_type":"slug","_key":"fda06462-f142-424a-9687-d6821b80cd96"},"navigationNameAsString":"","title":"Research \u0026 Development"},"_type":"menuItem"},{"submenu":[],"document":{"_id":"8845552e-3eb5-4133-b48a-66560e70981a","friendlyUrl":{"current":"/nl-nl/wat-we-doen/verzoek-om-sponsoring/","_type":"slug","_key":"fda06462-f142-424a-9687-d6821b80cd96"},"navigationNameAsString":"","title":"Verzoek om Sponsoring"},"_type":"menuItem","_key":"93837c80bd00056896f74218fe593570"}],"document":{"title":"WAT WE DOEN","partialPageCallToActionLink":null,"partialPageHeading":"Ons werkveld","navigationNameAsString":"","friendlyUrl":{"current":"/nl-nl/wat-we-doen/","_type":"slug","_key":"b33507ee-74f4-4d5d-beed-6bdd00d914cf"},"partialPageCallToActionText":"Lees verder","partialPageIntroAsString":"\u003cdiv\u003eTakeda zet zijn transformatie voort naar een agile en innovatieve wereldwijde farmaceutische leider, die tegemoetkomt aan de behoeften van patiënten en artsen wereldwijd.\u003c/div\u003e","featuredContent":null,"_id":"b6e8a5c2-9ba2-442c-baf9-79ef84d80249__i18n_nl-NL"},"_type":"menuItem"},{"submenu":[{"submenu":[{"submenu":null,"document":{"_id":"d4098da9-6782-4b5d-a049-ead19331f309","friendlyUrl":{"current":"/nl-nl/Onze-verhalen/innovatie/takeda-anticipeert-op-de-toekomst-met-innovaties/","_type":"slug","_key":"704d2e3d-e23f-4492-ba60-8fb03c88c1d0"},"navigationNameAsString":"","title":"Takeda anticipeert op de toekomst met innovaties"},"_type":"menuItem","_key":"a486166e-3407-4cca-a3d6-ad46f8656f02"},{"_key":"0e656fea-e787-47dc-ae23-6a1573994c61","submenu":null,"document":null,"_type":"menuItem"}],"document":null,"_type":"menuItem","_key":"33ededfe-6464-4d04-8d1f-184c3bfcd50a"},{"_type":"menuItem","_key":"b73e18f5-58a8-45c7-a0c0-ae8d6c932c99","submenu":[{"document":null,"submenu":null,"_type":"menuItem","_key":"a9535720-1afc-4963-a21b-dd734429d795"},{"_key":"081252d5-f800-486d-a332-c5696178b350","document":null,"submenu":null,"_type":"menuItem"}],"document":null},{"submenu":[{"_type":"menuItem","_key":"64587029-6b5d-48ca-8e50-e94ba7cd861f","document":null,"submenu":null}],"document":null,"_type":"menuItem","_key":"db4f5c29-78e9-4dc0-8374-84261f7b8ce2"}],"document":{"partialPageCallToActionText":"Lees verder","partialPageCallToActionLink":null,"featuredContent":null,"partialPageIntroAsString":"\u003cdiv\u003eOntdek de verhalen van Takeda over innovatie, zorg en ons erfgoed\u003c/div\u003e","_id":"14479174-6503-484f-8d86-87d249c418c5__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/Onze-verhalen/","_type":"slug","_key":"8d0eb91f-2285-4ddd-878a-7ba663d86f04"},"navigationNameAsString":"","title":"Onze verhalen","partialPageHeading":"Onze verhalen"},"_type":"menuItem","_key":"19b800e0-0315-4fe9-9350-72703540c9a9"},{"_key":"f76bbfc7-9585-484f-815f-9a166ea6210c","submenu":[{"submenu":[],"document":{"_id":"e32b3b56-9f3d-4b0e-9ca3-dec84cdd09f4","friendlyUrl":{"current":"/nl-nl/maatschappelijk-ondernemen/maatschappelijk-verantwoord-ondernemen/","_type":"slug","_key":"4d4033f7-2f1c-4364-9750-27ba1fde7d4f"},"navigationNameAsString":"","title":"Maatschappelijk verantwoord ondernemen"},"_type":"menuItem","_key":"367dcd43-a291-4dce-bd1c-3be7ec8df9e4"}],"document":{"_id":"c97319bc-d412-46c9-8d68-8fb5a8560bad__i18n_nl-NL","friendlyUrl":{"current":"/nl-nl/maatschappelijk-ondernemen/","_type":"slug","_key":"87240004-fc1b-4ce6-bad9-6a6a19469120"},"partialPageCallToActionLink":null,"partialPageIntroAsString":"\u003cdiv\u003eTakeda hecht veel waarde aan Maatschappelijk Verantwoord Ondernemen (MVO). De inzet voor MVO is verweven in onze bedrijfsstrategie en dagelijkse praktijken.\u003c/div\u003e","featuredContent":null,"navigationNameAsString":"","title":"Maatschappelijk ondernemen","partialPageCallToActionText":"Lees verder","partialPageHeading":"Takeda's CSR"},"_type":"menuItem"}],"requirePageTemplate":true,"includeRoot":false,"requireVisibleInMenu":true,"levelToTake":3,"root":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094","_type":"reference"}},{"followUsLinks":[{"targetGroup":"Journalists","url":"https://www.linkedin.com/company/takeda-pharmaceuticals/","network":"Linkedin"},{"url":"http://www.twitter.com/takedapharma","network":"Twitter","targetGroup":"Journalists"}],"copyrightNoticeAsString":"\u003cdiv\u003eCopyright 1995-2025 Takeda Pharmaceutical Company Limited. All rights reserved.\u003cbr\u003e\u003cbr\u003eC-ANPROM/NL/GEN/0045-NOV 2023\u003c/div\u003e","footerLinks":[{"title":"GEBRUIKSVOORWAARDEN","_type":"linkItem","href":"/terms-of-use/?epslanguage=en","text":"GEBRUIKSVOORWAARDEN","_key":"aef7137b-9182-48d7-88e7-116142361839"},{"_key":"43378252-1e19-4e4d-a997-c05e5c2e8f09","title":"Privacyverklaring","_type":"linkItem","href":"/nl-nl/privacyverklaring/?epslanguage=nl-NL","text":"Privacyverklaring"},{"title":"Toegankelijkheidsverklaring","target":"_blank","_type":"linkItem","href":"/accessibility-statement/?lang=nl","text":"Toegankelijkheidsverklaring","_key":"680e8191-62c7-4a4e-91a7-99541cccb689"},{"_key":"3581c76b-6de3-478c-827b-453ae0a58f02","_type":"linkItem","href":"/cookie-policy/","text":"Cookie Policy"}],"_key":"e52381f5-ad8c-4a31-96ae-eea4b2f6e17b","footerBlocks":[{"_type":"countrySelectorLinkBlock","link":"/worldwide/","linkText":"Nederland","_key":"c2857b46-7331-4f4b-8c43-e6c290f067dc","flagUrl":{"_type":"imageFile","_key":"821c207a-60d5-434b-a838-d110f5d1793d","url":{"_type":"cloudinary.asset","_version":1,"_key":"21e574f2-281a-4042-84c2-f8d36dc5abb3","width":900,"public_id":"legacy-dotcom/globalassets/country-flags/nl","height":600,"format":"png","url":"http://assets-dam.takeda.com/image/upload/v1670931340/legacy-dotcom/globalassets/country-flags/nl.png","bytes":518,"created_at":"2022-09-09T10:45:49Z","resource_type":"image","version":1670931340,"secure_url":"https://assets-dam.takeda.com/image/upload/v1670931340/legacy-dotcom/globalassets/country-flags/nl.png","type":"upload"},"excludeFromSearch":false,"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHBAMAAADDgsFQAAAAD1BMVEW1wdjks7chRouuHCj///+gCMgLAAAAGklEQVQI12MwBgEGCCkIAgwuIMAAAUogACEBdLUE/MUBSE4AAAAASUVORK5CYII="}},{"_type":"htmlBlock","html":"\u003cscript\u003e\n(function() {\n var pageLanguage = document.getElementsByTagName('html')[0].getAttribute('lang');\n if (pageLanguage != null) {\n var match = pageLanguage.match(/ja|ja-JP|ko|kok|kok-IN|ko-KP|ko-KR|km|km-KH|kn|kn-IN|zh|zh-CHS|zh-CHT|zh-CN|zh-Hans|zh-Hans-HK|zh-Hans-MO|zh-Hant|zh-HK|zh-MO|zh-SG|zh-TW|zgh|zgh-Tfng|zgh-Tfng-MA/g);\n if (!document.querySelector(\"#tinymce\") \u0026\u0026 match == null) {\n var aSpans = document.querySelectorAll('.custom-shy'),\n nSpans = aSpans.length;\n for (i = 0; i \u003c nSpans; i++) aSpans[i].outerHTML = '\u0026shy;';\n }\n }\n\n var tempDiv = document.createElement('div');\n tempDiv.setAttribute(\"id\", \"tinymce\");\n document.body.appendChild(tempDiv);\n})();\n\u003c/script\u003e","_key":"7d51239b-7e28-4d57-94b1-737608c63103","displayOption":""}],"_type":"footerBlock","additionalBlocks":[{"_type":"externalLinkDisclaimerBlock","isCancelBeforeConfirm":false,"_key":"723ace4c-b357-4ad8-a57b-368bbcbab0b8","displayOption":"","cancelButtonText":"Annuleer","disclaimerTextAsString":"\u003cdiv\u003eU verlaat deze website en opent een website die niet wordt beheerd door Takeda Nederland bv. De inhoud van deze website valt niet onder de verantwoordelijkheid van Takeda Nederland bv.\u003c/div\u003e","okButtonText":"OK"},{"_key":"968b4c44-6c17-48e6-ac1d-366fa751267b","displayOption":"","customCssClass":"","layout":"","backgroundColor":"Transparent","contentAsString":"","_type":"richTextBlock"}],"goToTopText":"TOP","pageCodeLabel":"","socialMediaText":"Verbind je met ons:"}],"useNotoSansKr":false,"useNotoSansJp":false,"imageWarningSizeLimit":0,"contentFolderWasParent":true,"visibleInMenu":false,"_rev":"e4ZPr5O1VFp3drFicee6Ss","contentSettings":[{"breadcrumbIncludeStartPage":true,"brightcoveAccountId":"2299575749001","shareLabel":"","_type":"siteGlobalContentBlock","ourStoriesSectionHeadingAsString":"\u003cdiv\u003e\u003cspan\u003eAlle verhalen\u003c/span\u003e\u003c/div\u003e","_key":"d26ed924-53ef-4bc0-9ce8-87b7c80991c9","searchResultPageLink":{"childSortOrder":"createdDescending","language":"nl-NL","contentFolderWasParent":false,"_type":"sectionPage","hideBreadCrumb":false,"optimizelyId":"902","partialPageCallToActionText":"Learn more","partialPageHeading":"","visibleInMenu":false,"parentWasSkipped":false,"shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"a4138404-194a-4d10-afa8-38dbaefdb755"},"title":"Zoeken","_base":{"_weak":true,"_ref":"bf101a93-b8c5-4d6b-8d64-1f83b3f88593","_type":"reference"},"customCssClass":"","_langRefs":null,"_updatedAt":"2018-01-13T08:52:40Z","_id":"bf101a93-b8c5-4d6b-8d64-1f83b3f88593__i18n_nl-NL","showNewInLanguages":"","startPublish":"2018-01-13T08:52:40.147+00:00","urlSegment":"/nl-nl/search/","friendlyUrl":{"_key":"497bf4c2-352d-41d0-9a5a-3b16bf01458c","current":"/nl-nl/search/","_type":"slug"},"theme":"","_createdAt":"2018-01-13T08:48:09Z","parent":{"_type":"reference","_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL"},"releaseDate":"2018-01-13T08:52:40.147+00:00","_rev":"AMR5TWoIIn3XFQvA5NVWpk","shortUrl":"https://bit.ly/2sautmq","canonicalUrl":"https://www.takeda.com/search/","linkType":"normal","hideInThisSection":false,"hideFooter":false,"sortIndex":600,"trackingRoot":false,"hideHeader":false,"hideSocialSharingButtons":false,"seo":{"targetGroup":0,"indexing":0,"_type":"seoBlock","_key":"3575efac-180e-4170-85cb-12deaeae32fe","openGraphImage":""},"partialPageThumbnailAlt":"","excludeFromSearch":true,"mainContentArea":[{"mostRecentLabel":"","showingResultLabel":"Resultaten weergeven voor","_key":"28597c5c-f9f8-4736-bb51-7a2a6fa073dd","searchExcludeVideos":false,"hideTypesFilter":true,"allTypesLabel":"","searchButtonLabel":"invoeren","searchRootMediaLink":{"_type":"reference","_weak":true,"_ref":"d447805c-4e17-47bd-a838-909a81afaa78"},"noResultTextAsString":"\u003cdiv\u003eGeen resultaten\u003c/div\u003e","hideTopicsFilter":true,"numberOfPages":5,"heading":"Zoekresultaten","hideChronologyFilter":true,"showingSynonymsLabel":"Zoek in plaats daarvan naar","_type":"searchResultBlock","displayOption":"full","searchExcludeImages":true,"isNewsroom":false,"searchExcludeContentMedia":false,"allTopicsLabel":"","layout":"simplewithexcerpt","allYearsLabel":"","dateFormat":"","numberOfResultsPerPage":10,"searchExcludePdFs":false,"descriptionExcerptLength":200,"searchFieldPlaceholder":"Zoek op de website","searchRootPageLink":{"_weak":true,"_ref":"719d1b8a-9834-4b1f-8b58-1c0063ac3094","_type":"reference"},"childrenPagesOnNoQuery":false,"searchDefaultTerm":"","numberOfResultsLabel":"resultaten","hideNewsListHeader":false,"searchResultSortOrder":4,"chronologyFilter":""}]},"newsListingPageLink":{"_id":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","seo":{"indexing":0,"_type":"seoBlock","_key":"fb177da1-af0e-4dd7-bd5b-d8161d67171c","openGraphImage":"","title":"Nieuwsberichten","openGraphTitle":"Nieuwsberichten","targetGroup":0},"optimizelyId":"9143","showNewInLanguages":"","shortUrl":"https://takeda.info/2YFVlHQ","startPublish":"2018-01-11T07:41:02.123+00:00","releaseDate":"2018-01-11T07:41:02.123+00:00","childSortOrder":"index","hideHeader":false,"title":"Nieuwsberichten","sortIndex":100,"language":"nl-NL","mainContentArea":[{"isNewsroom":true,"searchDefaultTerm":"*","hideNewsListHeader":false,"allYearsLabel":"Alle","noResultTextAsString":"\u003cdiv\u003eGeen resultaten...\u003c/div\u003e","hideTypesFilter":false,"_key":"21ddbd96-2069-4158-b4cd-4c7952635998","allTypesLabel":"","numberOfPages":5,"searchExcludeContentMedia":false,"displayOption":"full","childrenPagesOnNoQuery":false,"mostRecentLabel":"Laatste 12 maanden","chronologyFilter":"#all,#last12months,2022,2021,2020,2019,2018,2017,2016,2015,2014","searchExcludeVideos":false,"dateFormat":"","_type":"searchResultBlock","numberOfResultsLabel":"","searchExcludeImages":false,"searchButtonLabel":"invoeren","layout":"simplegroupbymonth","hideTopicsFilter":false,"showingResultLabel":"","allTopicsLabel":"","searchFieldPlaceholder":"Zoeken","searchRootPageLink":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a","_type":"reference"},"numberOfResultsPerPage":9,"searchResultSortOrder":1,"hideChronologyFilter":false,"showingSynonymsLabel":"","descriptionExcerptLength":200,"searchExcludePdFs":false,"heading":""}],"urlSegment":"/nl-nl/nieuws/Persberichten/","headingAsString":"\u003cdiv\u003eNieuwsberichten\u003c/div\u003e","partialPageHeading":"","_langRefs":null,"hideFooter":false,"hideSocialSharingButtons":false,"visibleInMenu":true,"_type":"contentPage","customCssClass":"","hideSideMenu":false,"_updatedAt":"2024-02-20T12:45:52Z","parentWasSkipped":false,"_base":{"_type":"reference","_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a"},"trackingRoot":false,"shortcut":{"_type":"shortcut","shortcutType":"Normal","_key":"3599f88a-6999-4826-8cd6-a3361312fce2"},"partialPageThumbnailAlt":"","parent":{"_weak":true,"_ref":"7bea32ce-d307-498a-820f-a0820b4a4486__i18n_nl-NL","_type":"reference"},"partialPageCallToActionText":"Learn more","friendlyUrl":{"current":"/nl-nl/nieuws/Persberichten/","_type":"slug","_key":"368c20b8-2e51-4e3e-a485-3d96da824455"},"contentFolderWasParent":false,"hideInThisSection":false,"hideBreadCrumb":false,"_rev":"JM05JdyqK0pFIm8vWHvhzM","canonicalUrl":"https://www.takeda.com/newsroom/newsreleases/","linkType":"normal","_createdAt":"2017-12-22T06:21:55Z","excludeFromSearch":false},"displayOption":"full","downloadLabel":"","brightcovePlayerId":"r1m84eZA","searchPanelPlaceholderText":"Zoeken","notFoundPageLink":null,"oGimageUrl":{"excludeFromSearch":false,"_type":"imageFile","_key":"98deec54-2221-4fac-9688-89cf8bce51f5","url":{"public_id":"legacy-dotcom/globalassets/corporate/landing-page-takeda-logo","resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1675248866/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png","type":"upload","format":"png","_version":1,"_type":"cloudinary.asset","created_at":"2022-09-09T10:43:06Z","bytes":4857,"width":644,"_key":"b27188f6-57fc-4bc2-9f84-ca132769b829","version":1675248866,"height":643,"url":"http://assets-dam.takeda.com/image/upload/v1675248866/legacy-dotcom/globalassets/corporate/landing-page-takeda-logo.png"},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAG1BMVEX////4zc71srT86er98PD+9vbzpqn74+T73+ACeip6AAAAIklEQVQIHWPAAsKNCxgYGBObxQwYmISUkgQYGEJcXBkwAQBwLQOrR0EsTQAAAABJRU5ErkJggg=="}},{"targetGroup":6,"hideShareViaLinkedin":false,"hideShareViaFacebook":false,"labelText":"Delen:","displayOption":"full","hideShareViaTwitter":false,"mailToBody":"Groeten,\n\nIk vond dit interessant en ik zou het graag met je willen delen.\n\n","mailToSubject":"Ik wil dit graag met je delen.","_key":"170a1f3a-fb3c-40f9-a23d-f6c85e67cd5c","bitlyGenericAccessToken":"b93b10badf2abcefa56f247736ac164b88c731d2","_type":"socialSharingBlock","hideShareViaEmail":false},{"_key":"d1870e89-1990-4857-a95b-6c00a42dc131","displayOption":"full","_type":"newsItemActionBlock","rssFeedUrl":"https://www.takeda.com/system/news-releases-rss/"},{"customFields":[{"isEnabled":true,"_type":"dataFieldViewModel","name":"version","_key":"afe80c10-1cf0-4544-8899-7c38b3922fb3","value":""},{"value":"Takeda Corporate com","isEnabled":true,"_type":"dataFieldViewModel","name":"website_name","_key":"320d5c86-2ccf-4e9c-ab24-ccc3c9de8fa0"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"cluster","_key":"299d96d1-0bcd-487e-b9c2-bf38ce101a01","value":"www.takeda.com/nl-nl"}],"_type":"gtmSettingsBlock","headScript":"\u003c!-- Bing Webmaster tool --\u003e\n\u003cmeta name=\"msvalidate.01\" content=\"E15E71DA876B72B5ACE966AC329C32BA\" /\u003e\n\u003c!-- Baidu Webmaster tool --\u003e\u003cmeta name=\"baidu-site-verification\" content=\"PHSoqJntj0\" /\u003e\n\n\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-K75R39');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e\n\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-5XBTH5B');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e\n\n\u003c!-- idio Analytics Tracking Code --\u003e\n\u003cscript type=\"text/javascript\"\u003e\n // Set client and delivery\n \n _iaq = [\n ['client', '54a09b6302244fd3b7dd8dd141292d46'],\n ['delivery', 469],\n ['track', 'consume']\n ];\n \n // Include the Idio Analytics JavaScript\n !function(d,s){var ia=d.createElement(s);ia.async=1,s=d.getElementsByTagName(s)[0],ia.src='//s.usea01.idio.episerver.net/ia.js',s.parentNode.insertBefore(ia,s)}(document,'script');\n // Include the Idio PDF Tracking JavaScript\n !function(t,e){var a=t.attachEvent?'on':'';t[a?'attachEvent':'addEventListener'](a+'click',function(t){for(t=t.srcElement||t.target;t\u0026\u0026'a'!==t.tagName\u0026\u0026'A'!==t.tagName\u0026\u0026!t.href;)t=t.parentNode;if(t){var a=t.href,n=e.protocol+'//'+e.host;0===a.indexOf(n)\u0026\u0026/\\.pdf(\\?|#|$)/i.test(a)\u0026\u0026_iaq.push(['track','consume',a])}})}(document,location);\n\u003c/script\u003e\n\u003c!-- / idio Analytics Tracking Code --\u003e\n\n\u003cscript type='text/javascript'\u003e\n var zaius = window['zaius']||(window['zaius']=[]);zaius.methods=[\"initialize\",\"onload\",\"event\",\"entity\",\"identify\",\"anonymize\",\"dispatch\"];zaius.factory=function(e){return function(){var t=Array.prototype.slice.call(arguments);t.unshift(e);zaius.push(t);return zaius}};(function(){for(var i=0;i\u003czaius.methods.length;i++){var method=zaius.methods[i];zaius[method]=zaius.factory(method)}var e=document.createElement(\"script\");e.type=\"text/javascript\";e.async=true;e.src=(\"https:\"===document.location.protocol?\"https://\":\"http://\")+\"d1igp3oop3iho5.cloudfront.net/v2/eTtqWkmJ088MKBGQuRlrFA/zaius-min.js\";var t=document.getElementsByTagName(\"script\")[0];t.parentNode.insertBefore(e,t)})();\n \n // Edits to this script should only be made below this line.\n zaius.event('pageview');\n\u003c/script\u003e","_key":"278b1278-ec1c-4148-b79f-06ba91853c8d","displayOption":"full","enabled":true,"mappedProperties":[{"_key":"b920cd56-128e-4af3-9825-7a4fb2605974","value":"ContentLink","isEnabled":false,"_type":"dataFieldViewModel","name":"page_id"},{"name":"page_name","_key":"e40c7bdb-a3ee-4647-b884-8a3b2b6c2a4d","value":"Name","isEnabled":true,"_type":"dataFieldViewModel"},{"_type":"dataFieldViewModel","name":"page_language","_key":"27e7a760-cf8d-4d7b-8ed3-2cd2ed9aa3f0","value":"LanguageID","isEnabled":true},{"isEnabled":false,"_type":"dataFieldViewModel","name":"page_type","_key":"6f464395-8ef8-4227-bf1d-5cb3174ca0ee","value":"PageTypeName"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"page_url","_key":"ca65bef3-52cc-4f87-b080-b4d372001d13","value":"LinkURL"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"section","_key":"db65d509-4b22-4431-af65-ead1d2854583","value":"PageSection"},{"isEnabled":true,"_type":"dataFieldViewModel","name":"page_error","_key":"35066e0f-e45b-471b-a269-085eeb339c28","value":"PageError"},{"value":"TargetGroup","isEnabled":true,"_type":"dataFieldViewModel","name":"target_group","_key":"6f241189-f0b4-43fb-b3ba-13cb727486af"},{"name":"ip_address","_key":"8ce04c92-2ced-49e5-8f53-86a562fd8655","value":"IPAddress","isEnabled":true,"_type":"dataFieldViewModel"}],"bodyScript":"\u003c!-- Google Tag Manager (noscript) --\u003e\n\u003cnoscript\u003e\u003ciframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-K75R39\" height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"\u003e\u003c/iframe\u003e\u003c/noscript\u003e\n\u003c!-- End Google Tag Manager (noscript) --\u003e\n\u003c!-- Google Tag Manager (noscript) --\u003e\n\u003cnoscript\u003e\u003ciframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B\"\nheight=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"\u003e\u003c/iframe\u003e\u003c/noscript\u003e\n\u003c!-- End Google Tag Manager (noscript) --\u003e"}],"trackingRoot":false,"useNotoSansTc":false,"_updatedAt":"2025-01-14T14:26:43Z","hideFooter":false,"_base":{"_weak":true,"_ref":"f6caa076-f145-407f-b409-1b3e38b0e08a","_type":"reference"},"imageWarningText":"","optimizelyId":"890","hideHeader":false,"_langRefs":null,"canonicalUrl":"https://www.takeda.com/","friendlyUrl":{"current":"/nl-nl/system/settings/","_type":"slug","_key":"2b072b24-182b-4138-a921-202f348c727d"}},"pageData":{"urlSegment":"/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen","_type":"newsItemPage","_rev":"MDZjMGfJgf06ct7Ssaf7Q5","visibleInMenu":false,"parent":{"_weak":true,"_ref":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","_type":"reference"},"headingAsString":"\u003cdiv\u003eTakeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040.\u003c/div\u003e","trackingRoot":false,"seo":{"title":"Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen\"","descriptionString":"In de podcastserie \"Onderweg naar Zorgen\" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen in de ouderenzorg van 2040.","openGraphTitle":"Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen\"","_type":"seoBlock","openGraphDescription":"In de podcastserie \"Onderweg naar Zorgen\" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen in de ouderenzorg van 2040.","displayOption":""},"hideInThisSection":false,"excludeFromSearch":false,"hideSocialSharingButtons":false,"__STATIC":{"lv1":{"translationMetadataId":"08sdc3VS02r1AeJ6JPPR25","localId":"7bea32ce-d307-498a-820f-a0820b4a4486__i18n_nl-NL","title":"Nieuws","url":"/nl-nl/nieuws/"},"isCurrentLv1":false,"lv2":[{"translationMetadataId":"hOy10qbiXBGAt5MTQoESnm","localId":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","title":"Nieuwsberichten","url":"/nl-nl/nieuws/Persberichten/"}],"selectedLv2":{"translationMetadataId":"hOy10qbiXBGAt5MTQoESnm","localId":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","title":"Nieuwsberichten","url":"/nl-nl/nieuws/Persberichten/"},"lv3":[],"selectedLv3":null},"_id":"cieGN5lNRGWc3997qnWdsB","title":"Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040","hideHeader":false,"canonicalUrl":"https://www.takeda.com/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen","taxonomies":[],"language":"nl-NL","_createdAt":"2023-09-04T12:41:41Z","mainContentArea":[{"_type":"imageFile","partialPageThumbnail":{"_type":"imageFile","partialPageThumbnail":{"displayOption":"","_type":"imageFile","partialPageThumbnail":{"_type":"imageFile","partialPageThumbnail":{"_type":"imageFile","partialPageThumbnail":{"partialPageThumbnail":{"displayOption":"","_type":"imageFile","partialPageThumbnail":{"_type":"imageFile","partialPageThumbnail":{"_type":"imageFile","displayOption":""},"displayOption":""}},"displayOption":"","_type":"imageFile"},"displayOption":""},"displayOption":""}},"displayOption":"twothird"},"_key":"6b43d416cbf7","displayOption":"twothird","url":{"created_at":"2023-09-04T12:23:43Z","access_control":[],"created_by":{"id":"5ef77c2a61e1975357a3b7126870c4","type":"user"},"resource_type":"image","tags":[],"version":1693830223,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","type":"upload","public_id":"legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ","bytes":126358,"uploaded_by":{"id":"5ef77c2a61e1975357a3b7126870c4","type":"user"},"_key":"NNRxXjLcrn7oZm9ExoAQS","access_mode":"public","width":1024,"duration":null,"secure_url":"https://assets-dam.takeda.com/image/upload/v1693830223/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ.jpg","url":"http://assets-dam.takeda.com/image/upload/v1693830223/legacy-dotcom/siteassets/nl-nl/home/news/2023/PodcastONZ.jpg","_version":1,"_type":"cloudinary.asset","height":768},"blurDataUrl":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAICAMAAAD3JJ6EAAAAhFBMVEVgjX1lfHJPb2BlmIZkkYBVSUISFhRhkoQ5NzJDZFh6iHpMRTxihXQwOT1zpZJPVFdJPjNTe3OMWk9oWEohIR6dZF4nMj1Zi36JfW9Uh3yklJRhZlyVfXJBV0taRDlUcmkoMy5TbHWJiYaLeoZpb19bU1CRep5pXEhwbHq9gnWki3HJnovF+lVOAAAAVElEQVQIHQXBhwKAEAAFwEeEUmjvtNf//193EEIwBpamAdoagkHPi4JbI0APKlFw50aipiOegtzHHsemlwrUeBqGnMsRb26vosi5TPA9ZZllk5XVD74iBPfNeUBxAAAAAElFTkSuQmCC"},{"backgroundColor":"","contentAsString":"\u003cp\u003ePaul en Aarnoud benaderen de thematiek in de podcastserie met een combinatie van realisme en optimisme. Ze bespreken de knelpunten en zoeken naar haalbare oplossingen voor wat zij als een \"stille crisis\" zien. Ze beschrijven zichzelf als \"twee vakidioten, werkzaam bij een innovatief farmaceutisch bedrijf\", waar ze talloze gesprekken voerden over de toekomst van de zorg, elk vanuit hun eigen perspectief. Met een diepgewortelde overtuiging dat er verandering nodig is in de zorg, vragen ze zich af waarom veranderingen in de ouderenzorg zo traag gaan. Ze willen de ‘stille crisis’ op de kaart zetten en de maatschappelijke steun voor (het zoeken naar) oplossingen vergroten. Pauls focus ligt op de toegankelijkheid van de zorg voor iedereen, terwijl Aarnoud gefascineerd is door de manier waarop Nederlanders ouder worden en welke rol technologie daarin kan spelen.\u003c/p\u003e\n\u003cp\u003eDe huidige podcastserie bestaat uit 4 afleveringen, waarin ze de luisteraar meenemen op onderzoek in 'het Lab', vervolgens gaan ze door naar 'de Spreekkamer’ waar ze in gesprek gaan met de hoofdgast, een expert uit het zorgveld. Ze sluiten dit gesprek af met het 'Recept' voor een betere ouderenzorg. Paul en Aarnoud sluiten elke aflevering af met hun aanbeveling voor de toekomst. Wil je meer informatie over deze podcastserie? Ga dan naar: \u003ca href=\"www.stemvandepatient.nl\"\u003ewww.stemvandepatient.nl\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eDeze podcast is gemaakt door Takeda Nederland. Als innovatief gezondheidsbedrijf heeft Takeda aandacht voor belangrijke ontwikkelingen in de zorg. Takeda is een wereldwijd, op waarden gebaseerd, R\u0026amp;D-gedreven biofarmaceutisch bedrijf. Ons hoofdkantoor staat in Japan. Wij zetten ons sinds 1781 in voor het ontdekken en leveren van levensveranderende behandelingen om patiënten te genezen of hun kwaliteit van leven te verbeteren. Daarbij laten we ons leiden door onze toewijding aan patiënten, onze mensen en de planeet. In Nederland zijn we actief sinds de jaren ‘50. Takeda richt zijn R\u0026amp;D-inspanningen op vier therapeutische gebieden: oncologie-hematologie, zeldzame genetische ziekten, neurowetenschappen en gastro-enterologie (GI). We doen ook gerichte R\u0026amp;D-investeringen in van plasma afgeleide therapieën en vaccins (\u003ca href=\"www.takeda.nl\"\u003ewww.takeda.nl\u003c/a\u003e).\u003c/p\u003e","_type":"richTextBlock","_key":"f0a507a4161f","content":null,"displayOption":""}],"_langRefs":null,"canonicals":null,"hideFooter":false,"friendlyUrl":{"current":"/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen","_type":"slug"},"shortUrl":"https://bit.ly/45UUAfc","contentFolderWasParent":true,"releaseDate":"2023-09-05T07:00:00.000Z","hideBreadCrumb":false,"_updatedAt":"2023-09-05T07:01:26Z","mainBodyAsString":"\u003cp\u003e\u003cstrong\u003eHoofddorp, 5 september 2023. De zorg voor ouderen stevent af op grote uitdagingen. In 2040 zullen we maar liefst 4,9 miljoen inwoners van 65 jaar en ouder tellen. Concreet betekent dit dat een kwart van de totale Nederlandse bevolking als ‘oudere’ wordt aangemerkt. Deze aanzienlijke groep zal extra zorg en ondersteuning nodig hebben, terwijl het aantal mensen in de werkzame leeftijd juist afneemt. In de podcastserie \"Onderweg naar Zorgen\" onderzoeken Paul Slobbe en Aarnoud Overkamp, samen met experts uit het zorgveld, de belangrijkste problemen, uitdagingen en ontwikkelingen die voor ons liggen om uiteindelijk advies te kunnen geven over hoe we met meer vertrouwen naar de toekomst kunnen kijken. Alle afleveringen zijn vanaf nu te beluisteren via diverse podcast apps.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDe zoektocht naar mogelijke oplossingen voor de toekomstige problematiek in de ouderenzorg is een reis die niet alleen de huidige uitdagingen belicht, maar ook een licht werpt op de mogelijkheden die voor ons liggen. De serie behandelt een breed scala aan thema’s zoals de rol van technologie, kunstmatige intelligentie en innovatieve burgerinitiatieven in de ouderenzorg. \u003c/p\u003e","hideSideMenu":false,"slug":{"current":"/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen","_type":"slug"},"newsListingPageLink":"/nl-nl/nieuws/Persberichten/","breadcrumbItems":[{"parentTranslationMetadataIds":null,"_id":"719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","_type":"sectionPage","title":"HOME","href":"/nl-nl/","parentBase":{"_ref":null}},{"_id":"7bea32ce-d307-498a-820f-a0820b4a4486__i18n_nl-NL","_type":"contentPage","title":"Nieuws","href":"/nl-nl/nieuws/","parentBase":{"_ref":["719d1b8a-9834-4b1f-8b58-1c0063ac3094","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bg-BG","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bs-Latn-BA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_cs-CZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_da-DK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-AT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-DE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_el-GR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-AU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-BE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GB","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-AR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-CO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-EC","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-ES","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-MX","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-PE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_et-EE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fi-FI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-FR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hr-HR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hu-HU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_id-ID","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_it-IT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja-JP","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_kk-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ko-KR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lt-LT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lv-LV","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pl-PL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-BR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-PT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ro-RO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-RU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sk-SK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sl-SI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sr-Latn-RS","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sv-SE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_th-TH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uk-UA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uz-Cyrl-UZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-CN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-TW","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-MD","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR"]},"parentTranslationMetadataIds":["719d1b8a-9834-4b1f-8b58-1c0063ac3094","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bg-BG","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_bs-Latn-BA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_cs-CZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_da-DK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-AT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_de-DE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_el-GR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-AU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-BE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GB","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-IN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-US","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-AR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-CO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-EC","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-ES","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-MX","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_es-PE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_et-EE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fi-FI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-CH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_fr-FR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hr-HR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_hu-HU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_id-ID","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_it-IT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ja-JP","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_kk-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ko-KR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lt-LT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_lv-LV","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nl-NL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pl-PL","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-BR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_pt-PT","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ro-RO","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-KZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-RU","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sk-SK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sl-SI","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sr-Latn-RS","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_sv-SE","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_th-TH","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uk-UA","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_uz-Cyrl-UZ","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-CN","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-HK","719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_zh-TW","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_en-GI","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_he-IL","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_nn-NO","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_ru-MD","drafts.719d1b8a-9834-4b1f-8b58-1c0063ac3094__i18n_tr-TR"]},{"_id":"dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","_type":"contentPage","title":"Nieuwsberichten","href":"/nl-nl/nieuws/Persberichten/","parentBase":{"_ref":["7bea32ce-d307-498a-820f-a0820b4a4486","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_bg-BG","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-AT","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-CH","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-DE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_el-GR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-BE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-CA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-US","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-AR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-CO","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-EC","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-PE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fi-FI","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-CA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-CH","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-FR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_it-IT","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ja","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_kk-KZ","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ko-KR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_nl-NL","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_pl-PL","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ro-RO","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ru-KZ","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ru-RU","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_sv-SE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_uk-UA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_zh-CN","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_zh-TW"]},"parentTranslationMetadataIds":["7bea32ce-d307-498a-820f-a0820b4a4486","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_bg-BG","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-AT","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-CH","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_de-DE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_el-GR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-BE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-CA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_en-US","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-AR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-CO","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-EC","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_es-PE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fi-FI","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-CA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-CH","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_fr-FR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_it-IT","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ja","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_kk-KZ","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ko-KR","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_nl-NL","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_pl-PL","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ro-RO","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ru-KZ","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_ru-RU","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_sv-SE","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_uk-UA","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_zh-CN","7bea32ce-d307-498a-820f-a0820b4a4486__i18n_zh-TW"]},{"_id":"cieGN5lNRGWc3997qnWdsB","_type":"newsItemPage","title":"Takeda lanceert nieuwe podcastserie “Onderweg naar zorgen” en duikt in de toekomst van ouderenzorg in Nederland in 2040","href":"/nl-nl/nieuws/Persberichten/2023/takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen","parentBase":{"_ref":["dde5a2ec-2787-4035-842d-c63e5bedf08a","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_bg-BG","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_el-GR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-CA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-US","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-AR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-CO","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-EC","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-PE","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_fi-FI","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_fr-CA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_it-IT","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ja","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ko-KR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_pl-PL","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ro-RO","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ru-KZ","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ru-RU","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_sv-SE","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_uk-UA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_zh-CN","drafts.dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_it-IT","71735f06-7c8d-4b5e-8c3b-3f4e998f39aa"]},"parentTranslationMetadataIds":["dde5a2ec-2787-4035-842d-c63e5bedf08a","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_bg-BG","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_el-GR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-CA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_en-US","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-AR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-CO","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-EC","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_es-PE","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_fi-FI","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_fr-CA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_it-IT","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ja","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ko-KR","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_nl-NL","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_pl-PL","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ro-RO","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ru-KZ","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_ru-RU","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_sv-SE","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_uk-UA","dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_zh-CN","drafts.dde5a2ec-2787-4035-842d-c63e5bedf08a__i18n_it-IT","71735f06-7c8d-4b5e-8c3b-3f4e998f39aa"],"active":true}]},"globalSiteSettings":{"oneTrustScriptAttributes":{"id":"3625bb82-8e0e-4be8-80d3-257e4f469168","autoBlockSrc":"https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js","src":"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js","_type":"oneTrustScriptAttributes"},"logo":{"_type":"image","asset":{"_ref":"image-934f4f2c06a8d0f9dd6de5e05696143e1b186758-512x512-png","_type":"reference"}},"_id":"000f3268-1464-4f3e-a14f-524ab5ecca53","scripts":[{"_type":"scriptTag","id":"matomo-script","_key":"b71b3c2c6d22","strategy":"beforeInteractive","async":false,"defer":false,"referrerPolicy":"","src":"data:text/javascript,%20%20var%20_mtm%20%3D%20window._mtm%20%3D%20window._mtm%20%7C%7C%20%5B%5D%3B%0A%20%20_mtm.push%28%7B%27mtm.startTime%27%3A%20%28new%20Date%28%29.getTime%28%29%29%2C%20%27event%27%3A%20%27mtm.Start%27%7D%29%3B%0A%20%20%28function%28%29%20%7B%0A%20%20%20%20var%20d%3Ddocument%2C%20g%3Dd.createElement%28%27script%27%29%2C%20s%3Dd.getElementsByTagName%28%27script%27%29%5B0%5D%3B%0A%20%20%20%20g.async%3Dtrue%3B%20g.src%3D%27https%3A%2F%2Fcdn.matomo.cloud%2Ftakeda.matomo.cloud%2Fcontainer_rTZNKGIx.js%27%3B%20s.parentNode.insertBefore%28g%2Cs%29%3B%0A%20%20%7D%29%28%29%3B"}],"locales":[{"_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGhg","nativeName":"українська","_type":"Locale","languageCode":"uk","regionCode":"UA","localeCode":"uk-UA","friendlyUrl":{"current":"/uk-ua/"},"_updatedAt":"2024-07-09T11:03:39Z","displayName":"Ukrainian - Ukraine","shortUrl":"https://bit.ly/3IL8ZRl","_rev":"08sdc3VS02r1AeJ6JPNuNN"},{"regionCode":"LT","localeCode":"lt-LT","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFNs","nativeName":"lietuvių","shortUrl":"https://bit.ly/3IKDmre","_rev":"08sdc3VS02r1AeJ6JPNuRt","isEnabled":true,"friendlyUrl":{"current":"/lt-lt/"},"_updatedAt":"2024-07-09T11:03:40Z","displayName":"Lithuanian - Lithuania","_type":"Locale","languageCode":"lt"},{"displayName":"English - Belgium","shortUrl":"https://bit.ly/3IK5niP","languageCode":"en","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACuU","friendlyUrl":{"current":"/en-be/"},"nativeName":"English","_rev":"08sdc3VS02r1AeJ6JPNuWP","_type":"Locale","regionCode":"BE","localeCode":"en-BE","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:03:42Z"},{"_id":"hOy10qbiXBGAt5MTQoADZO","friendlyUrl":{"current":"/en-us/"},"nativeName":"English","displayName":"English - United States","shortUrl":"https://bit.ly/3Prjbm4","_rev":"hOy10qbiXBGAt5MTQoAOmk","languageCode":"en","regionCode":"US","_updatedAt":"2024-07-09T11:03:43Z","_type":"Locale","localeCode":"en-US","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"friendlyUrl":{"current":"/es-mx/"},"nativeName":"español","displayName":"Spanish Castilian - Mexico","shortUrl":"https://bit.ly/43pfTp9","_type":"Locale","regionCode":"MX","localeCode":"es-MX","_id":"hOy10qbiXBGAt5MTQoADyx","_updatedAt":"2024-07-09T11:03:44Z","_rev":"08sdc3VS02r1AeJ6JPNuav","languageCode":"es","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"nativeName":"қазақ тілі","displayName":"Kazakh - Kazakhstan","shortUrl":"https://bit.ly/4aFWgvx","_rev":"08sdc3VS02r1AeJ6JPNufR","_type":"Locale","languageCode":"kk","localeCode":"kk-KZ","_id":"hOy10qbiXBGAt5MTQoAFDe","friendlyUrl":{"current":"/kk-kz/"},"_updatedAt":"2024-07-09T11:03:45Z","regionCode":"KZ","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"_id":"hOy10qbiXBGAt5MTQoACkG","nativeName":"Ελληνικά","displayName":"Modern Greek (1453-) - Greece","shortUrl":"https://bit.ly/3v9P9MM","regionCode":"GR","localeCode":"el-GR","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:03:47Z","_rev":"hOy10qbiXBGAt5MTQoAP7C","_type":"Locale","languageCode":"el","friendlyUrl":{"current":"/el-gr/"}},{"localeCode":"sv-SE","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/sv-se/"},"nativeName":"svenska","displayName":"Swedish - Sweden","shortUrl":"https://bit.ly/3PvuVDS","_rev":"hOy10qbiXBGAt5MTQoAPHQ","regionCode":"SE","_type":"Locale","languageCode":"sv","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGSL","_updatedAt":"2024-07-09T11:03:48Z"},{"nativeName":"Deutsch","shortUrl":"https://bit.ly/3IIgKrv","_rev":"hOy10qbiXBGAt5MTQoAPRe","_type":"Locale","languageCode":"de","regionCode":"AT","_updatedAt":"2024-07-09T11:03:49Z","displayName":"German - Austria","localeCode":"de-AT","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACUv","friendlyUrl":{"current":"/de-at/"}},{"_rev":"hOy10qbiXBGAt5MTQoAPbs","regionCode":"Cyrl","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/uz-uz/"},"_updatedAt":"2024-07-09T11:03:50Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGmn","nativeName":"ўзбекча","displayName":"Uzbek","shortUrl":"https://bit.ly/3Vt8J1g","_type":"Locale","languageCode":"uz","localeCode":"uz-Cyrl-UZ"},{"shortUrl":"https://bit.ly/3VudcRi","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"languageCode":"en","nativeName":"English","localeCode":"en","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAC5M","friendlyUrl":{"current":"/en/"},"_updatedAt":"2024-07-09T11:03:51Z","displayName":"English","_rev":"hOy10qbiXBGAt5MTQoAPm6"},{"localeCode":"en-CA","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACzb","friendlyUrl":{"current":"/en-ca/"},"_updatedAt":"2024-07-09T11:03:52Z","languageCode":"en","displayName":"English - Canada","shortUrl":"https://bit.ly/3vkDDhs","_rev":"08sdc3VS02r1AeJ6JPNumD","_type":"Locale","regionCode":"CA","nativeName":"English"},{"_rev":"hOy10qbiXBGAt5MTQoAQBf","_type":"Locale","languageCode":"et","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEEI","friendlyUrl":{"current":"/et-ee/"},"_updatedAt":"2024-07-09T11:03:53Z","displayName":"Estonian - Estonia","shortUrl":"https://bit.ly/3Ptha8E","regionCode":"EE","localeCode":"et-EE","_createdAt":"2024-07-09T11:03:36Z","nativeName":"eesti"},{"_rev":"iwSJAlC9N7TuVxGxCvbCH2","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEo5","nativeName":"magyar","displayName":"Hungarian - Hungary","shortUrl":"https://bit.ly/3vl6FgZ","localeCode":"hu-HU","friendlyUrl":{"current":"/hu-hu/"},"_updatedAt":"2024-07-09T11:03:54Z","_type":"Locale","languageCode":"hu","regionCode":"HU"},{"isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAETd","friendlyUrl":{"current":"/fr-ch/"},"_updatedAt":"2024-07-09T11:03:56Z","displayName":"French - Switzerland","shortUrl":"https://bit.ly/3TJVLdX","localeCode":"fr-CH","languageCode":"fr","regionCode":"CH","_createdAt":"2024-07-09T11:03:36Z","nativeName":"français","_rev":"hOy10qbiXBGAt5MTQoAQLt","_type":"Locale"},{"nativeName":"עברית","shortUrl":"https://bit.ly/3INh0W8","regionCode":"IL","localeCode":"he-IL","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEdr","_updatedAt":"2024-07-09T11:03:57Z","displayName":"Hebrew - Israel","_rev":"hOy10qbiXBGAt5MTQoAQbE","_type":"Locale","languageCode":"he","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/he-il/"}},{"_rev":"hOy10qbiXBGAt5MTQoAQlS","_type":"Locale","localeCode":"sr-Latn-RS","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/sr-rs/"},"nativeName":"srpski","shortUrl":"https://bit.ly/3TM6CnZ","regionCode":"Latn","_id":"hOy10qbiXBGAt5MTQoAGNE","_updatedAt":"2024-07-09T11:03:58Z","displayName":"Serbian","languageCode":"sr"},{"nativeName":"English","displayName":"English - Ireland","languageCode":"en","regionCode":"IE","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/en-ie/"},"_updatedAt":"2024-07-09T11:03:59Z","shortUrl":"https://bit.ly/4anUoXM","_rev":"08sdc3VS02r1AeJ6JPNuqj","_type":"Locale","localeCode":"en-IE","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADK3"},{"shortUrl":"https://bit.ly/3vl6Fxv","_rev":"hOy10qbiXBGAt5MTQoAQvg","regionCode":"HK","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGx1","friendlyUrl":{"current":"/zh-hk/"},"nativeName":"中文(繁體)","displayName":"Chinese - Hong Kong","_type":"Locale","languageCode":"zh","localeCode":"zh-HK","_updatedAt":"2024-07-09T11:04:00Z"},{"isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADPA","friendlyUrl":{"current":"/en-in/"},"displayName":"English - India","shortUrl":"https://bit.ly/3IMtbm1","_type":"Locale","languageCode":"en","localeCode":"en-IN","nativeName":"English","_rev":"iwSJAlC9N7TuVxGxCvbCQG","regionCode":"IN","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:04:01Z"},{"shortUrl":"https://bit.ly/3TIdQcu","_rev":"08sdc3VS02r1AeJ6JPNuvF","regionCode":"AU","localeCode":"en-AU","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"displayName":"English - Australia","_type":"Locale","languageCode":"en","_id":"hOy10qbiXBGAt5MTQoACpN","friendlyUrl":{"current":"/en-au/"},"_updatedAt":"2024-07-09T11:04:02Z","nativeName":"English"},{"_type":"Locale","regionCode":"KR","localeCode":"ko-KR","_createdAt":"2024-07-09T11:03:36Z","nativeName":"한국어","displayName":"Korean - Republic of Korea","shortUrl":"https://bit.ly/43oV0dH","_rev":"iwSJAlC9N7TuVxGxCvbCe6","_id":"hOy10qbiXBGAt5MTQoAFIl","_updatedAt":"2024-07-09T11:04:03Z","languageCode":"ko","isEnabled":true,"friendlyUrl":{"current":"/ko-kr/"}},{"languageCode":"ja","localeCode":"ja-JP","isEnabled":true,"_updatedAt":"2024-07-09T11:04:04Z","displayName":"Japanese - Japan","shortUrl":"https://bit.ly/3vcE6T1","_type":"Locale","regionCode":"JP","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAF8X","friendlyUrl":{"current":"/ja-jp/"},"nativeName":"日本語","_rev":"08sdc3VS02r1AeJ6JPNv6X"},{"localeCode":"hr-HR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEiy","friendlyUrl":{"current":"/hr-hr/"},"_updatedAt":"2024-07-09T11:04:05Z","nativeName":"hrvatski","_type":"Locale","regionCode":"HR","languageCode":"hr","_createdAt":"2024-07-09T11:03:36Z","displayName":"Croatian - Croatia","shortUrl":"https://bit.ly/4akhJK6","_rev":"hOy10qbiXBGAt5MTQoAR5u"},{"friendlyUrl":{"current":"/es-ve/"},"nativeName":"español","_rev":"iwSJAlC9N7TuVxGxCvbCrw","_type":"Locale","localeCode":"es-VE","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAE9B","displayName":"Spanish Castilian - Venezuela","shortUrl":"https://bit.ly/43qi77s","languageCode":"es","regionCode":"VE","isEnabled":true,"_updatedAt":"2024-07-09T11:04:07Z"},{"regionCode":"SK","localeCode":"sk-SK","isEnabled":true,"shortUrl":"https://bit.ly/3PsaMyA","_rev":"08sdc3VS02r1AeJ6JPNvFZ","_type":"Locale","languageCode":"sk","friendlyUrl":{"current":"/sk-sk/"},"_updatedAt":"2024-07-09T11:04:08Z","nativeName":"slovenčina","displayName":"Slovak - Slovakia","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAGD0"},{"friendlyUrl":{"current":"/id-id/"},"_updatedAt":"2024-07-09T11:04:09Z","_rev":"iwSJAlC9N7TuVxGxCvbD1A","regionCode":"ID","localeCode":"id-ID","_id":"hOy10qbiXBGAt5MTQoAEtC","languageCode":"id","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"nativeName":"Indonesia","displayName":"Indonesian - Indonesia","shortUrl":"https://bit.ly/3TM6BQX","_type":"Locale"},{"_type":"Locale","languageCode":"pl","regionCode":"PL","nativeName":"polski","shortUrl":"https://bit.ly/4amjl63","_rev":"08sdc3VS02r1AeJ6JPNvOb","localeCode":"pl-PL","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFiK","friendlyUrl":{"current":"/pl-pl/"},"displayName":"Polish - Poland","_updatedAt":"2024-07-09T11:04:11Z"},{"_rev":"08sdc3VS02r1AeJ6JPOkrF","_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAD9p","friendlyUrl":{"current":"/en-vi/"},"regionCode":"VN","shortUrl":"https://bit.ly/43uqNK3","_createdAt":"2024-07-09T11:03:36Z","languageCode":"en","_updatedAt":"2024-07-09T11:04:12Z","localeCode":"en-VN","displayName":"English - Viet Nam","isEnabled":true},{"shortUrl":"https://bit.ly/3IMGbYJ","_rev":"08sdc3VS02r1AeJ6JPOsOf","languageCode":"es","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADtq","_updatedAt":"2024-07-09T11:04:15Z","nativeName":"español","displayName":"Spanish Castilian - Spain","localeCode":"es-ES","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/es-es/"},"_type":"Locale","regionCode":"ES"},{"_updatedAt":"2024-07-09T11:04:18Z","displayName":"English - Hong Kong","localeCode":"en-HK","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/en-hk/"},"regionCode":"HK","_id":"hOy10qbiXBGAt5MTQoADEw","nativeName":"English","shortUrl":"https://bit.ly/3VKEMKf","_rev":"08sdc3VS02r1AeJ6JPOsXh","_type":"Locale","languageCode":"en"},{"regionCode":"BG","localeCode":"bg-BG","isEnabled":true,"friendlyUrl":{"current":"/bg-bg/"},"shortUrl":"https://bit.ly/43qluLU","_type":"Locale","_rev":"iwSJAlC9N7TuVxGxCveMh6","languageCode":"bg","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoACAT","_updatedAt":"2024-07-09T11:04:21Z","nativeName":"български","displayName":"Bulgarian - Bulgaria"},{"_id":"hOy10qbiXBGAt5MTQoAFxf","friendlyUrl":{"current":"/ro-ro/"},"nativeName":"română","displayName":"Romanian Moldavian Moldovan - Romania","_rev":"iwSJAlC9N7TuVxGxCveMqK","_type":"Locale","regionCode":"RO","localeCode":"ro-RO","_updatedAt":"2024-07-09T11:04:23Z","shortUrl":"https://bit.ly/3TqAmoW","languageCode":"ro","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true},{"displayName":"Russian - Kazakhstan","regionCode":"KZ","friendlyUrl":{"current":"/ru-kz/"},"_updatedAt":"2024-07-09T11:04:24Z","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"nativeName":"русский","shortUrl":"https://bit.ly/4antPC9","_rev":"08sdc3VS02r1AeJ6JPOseT","_type":"Locale","languageCode":"ru","localeCode":"ru-KZ","_id":"hOy10qbiXBGAt5MTQoAG2m"},{"nativeName":"suomi","displayName":"Finnish - Finland","shortUrl":"https://bit.ly/3INSd4o","_type":"Locale","languageCode":"fi","regionCode":"FI","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/fi-fi/"},"_updatedAt":"2024-07-09T11:04:26Z","_rev":"iwSJAlC9N7TuVxGxCveN4A","localeCode":"fi-FI","_id":"hOy10qbiXBGAt5MTQoAEJP"},{"displayName":"Chinese - China","_rev":"08sdc3VS02r1AeJ6JPOslF","regionCode":"CN","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAGru","friendlyUrl":{"current":"/zh-cn/"},"nativeName":"中文(简体) 旧版","_type":"Locale","languageCode":"zh","localeCode":"zh-CN","isEnabled":true,"_updatedAt":"2024-07-09T11:04:28Z","shortUrl":"https://bit.ly/3vvE3S9"},{"displayName":"Czech - Czechia Czech Republic","shortUrl":"https://bit.ly/3IRuxM8","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:04:30Z","_id":"hOy10qbiXBGAt5MTQoACKh","friendlyUrl":{"current":"/cs-cz/"},"nativeName":"čeština","_rev":"08sdc3VS02r1AeJ6JPOswX","languageCode":"cs","regionCode":"CZ","localeCode":"cs-CZ","isEnabled":true},{"displayName":"French - France","shortUrl":"https://bit.ly/3IIgOrf","_type":"Locale","localeCode":"fr-FR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEYk","friendlyUrl":{"current":"/fr-fr/"},"_updatedAt":"2024-07-09T11:04:31Z","nativeName":"français","_rev":"iwSJAlC9N7TuVxGxCveNVq","languageCode":"fr","regionCode":"FR","_createdAt":"2024-07-09T11:03:36Z"},{"regionCode":"DK","isEnabled":true,"friendlyUrl":{"current":"/da-dk/"},"nativeName":"dansk","displayName":"Danish - Denmark","languageCode":"da","localeCode":"da-DK","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoACPo","_updatedAt":"2024-07-09T11:04:33Z","shortUrl":"https://bit.ly/3TuPeT8","_rev":"08sdc3VS02r1AeJ6JPOt13","_type":"Locale"},{"shortUrl":"https://bit.ly/3Px8ZrY","languageCode":"fr","regionCode":"CA","localeCode":"fr-CA","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAEOW","nativeName":"français","_rev":"hOy10qbiXBGAt5MTQoCvdU","_type":"Locale","friendlyUrl":{"current":"/fr-ca/"},"_updatedAt":"2024-07-09T11:04:34Z","displayName":"French - Canada"},{"displayName":"Norwegian Nynorsk - Norway","_type":"Locale","languageCode":"nn","_id":"hOy10qbiXBGAt5MTQoAFdD","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/nn-no/"},"nativeName":"nynorsk","shortUrl":"https://bit.ly/3TIdRx4","_rev":"iwSJAlC9N7TuVxGxCveSry","regionCode":"NO","localeCode":"nn-NO","_updatedAt":"2024-07-09T11:04:36Z"},{"shortUrl":"https://bit.ly/3INixeP","_rev":"08sdc3VS02r1AeJ6JPOt7p","localeCode":"pt-PT","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFsY","displayName":"Portuguese - Portugal","_type":"Locale","languageCode":"pt","regionCode":"PT","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/pt-pt/"},"_updatedAt":"2024-07-09T11:04:38Z","nativeName":"português"},{"displayName":"Spanish Castilian - Argentina","shortUrl":"https://bit.ly/3vkDBpQ","_type":"Locale","regionCode":"AR","_createdAt":"2024-07-09T11:03:36Z","nativeName":"español","_rev":"08sdc3VS02r1AeJ6JPOtCL","languageCode":"es","localeCode":"es-AR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADeV","friendlyUrl":{"current":"/es-ar/"},"_updatedAt":"2024-07-09T11:04:39Z"},{"displayName":"German - Germany","_type":"Locale","regionCode":"DE","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/de-de/"},"_updatedAt":"2024-07-09T11:04:41Z","_id":"hOy10qbiXBGAt5MTQoACf9","nativeName":"Deutsch","shortUrl":"https://bit.ly/3IK5xXt","_rev":"08sdc3VS02r1AeJ6JPOtPt","languageCode":"de","localeCode":"de-DE","isEnabled":true},{"_type":"Locale","regionCode":"CO","localeCode":"es-CO","_createdAt":"2024-07-09T11:03:36Z","nativeName":"español","displayName":"Spanish Castilian - Colombia","shortUrl":"https://bit.ly/3IRuvUw","_rev":"iwSJAlC9N7TuVxGxCveTlK","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoADjc","_updatedAt":"2024-07-09T11:04:43Z","languageCode":"es","friendlyUrl":{"current":"/es-co/"}},{"regionCode":"NL","localeCode":"nl-NL","isEnabled":true,"friendlyUrl":{"current":"/nl-nl/"},"_updatedAt":"2024-07-09T11:04:44Z","nativeName":"Nederlands","displayName":"Dutch Flemish - Netherlands","shortUrl":"https://bit.ly/4aid2Aq","_rev":"08sdc3VS02r1AeJ6JPOtUP","_type":"Locale","languageCode":"nl","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFY6"},{"_id":"hOy10qbiXBGAt5MTQoADUH","nativeName":"English","displayName":"English - Malaysia","shortUrl":"https://bit.ly/3VsUKbr","_type":"Locale","localeCode":"en-MY","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_rev":"08sdc3VS02r1AeJ6JPOtbB","languageCode":"en","regionCode":"MY","friendlyUrl":{"current":"/en-my/"},"_updatedAt":"2024-07-09T11:04:47Z"},{"_updatedAt":"2024-07-09T11:04:48Z","shortUrl":"https://bit.ly/3INTZSO","_rev":"iwSJAlC9N7TuVxGxCveU3m","_type":"Locale","languageCode":"tr","localeCode":"tr-TR","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGcZ","nativeName":"Türkçe","displayName":"Turkish - Turkey","regionCode":"TR","_createdAt":"2024-07-09T11:03:36Z","friendlyUrl":{"current":"/tr-tr/"}},{"_updatedAt":"2024-07-09T11:04:50Z","localeCode":"ja","_rev":"08sdc3VS02r1AeJ6JPOtkD","shortUrl":"https://bit.ly/43qii2C","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_type":"Locale","_id":"hOy10qbiXBGAt5MTQoAF3Q","friendlyUrl":{"current":"/jp/"},"nativeName":"日本語","displayName":"Japanese","languageCode":"ja"},{"localeCode":"es-EC","_id":"hOy10qbiXBGAt5MTQoADoj","displayName":"Spanish Castilian - Ecuador","shortUrl":"https://bit.ly/3wYAdBo","_rev":"hOy10qbiXBGAt5MTQoCwIO","regionCode":"EC","isEnabled":true,"friendlyUrl":{"current":"/es-ec/"},"_updatedAt":"2024-07-09T11:04:52Z","nativeName":"español","_type":"Locale","languageCode":"es","_createdAt":"2024-07-09T11:03:36Z"},{"regionCode":"IT","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/it-it/"},"_updatedAt":"2024-07-09T11:04:54Z","shortUrl":"https://bit.ly/3TLXpLd","_rev":"08sdc3VS02r1AeJ6JPOuI5","_type":"Locale","localeCode":"it-IT","_id":"hOy10qbiXBGAt5MTQoAEyJ","nativeName":"italiano","displayName":"Italian - Italy","languageCode":"it"},{"_type":"Locale","regionCode":"GB","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/en-gb/"},"_updatedAt":"2024-07-09T11:04:56Z","displayName":"English - United Kingdom","shortUrl":"https://bit.ly/3IPgtD7","languageCode":"en","localeCode":"en-GB","_id":"hOy10qbiXBGAt5MTQoAD4i","nativeName":"English","_rev":"08sdc3VS02r1AeJ6JPOuMb"},{"displayName":"Latvian - Latvia","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAFSz","_updatedAt":"2024-07-09T11:04:58Z","nativeName":"latviešu","shortUrl":"https://bit.ly/4akyDID","_rev":"08sdc3VS02r1AeJ6JPOuR7","_type":"Locale","languageCode":"lv","regionCode":"LV","localeCode":"lv-LV","isEnabled":true,"friendlyUrl":{"current":"/lv-lv/"}},{"_rev":"08sdc3VS02r1AeJ6JPOuVd","localeCode":"es-PE","_id":"hOy10qbiXBGAt5MTQoAE44","friendlyUrl":{"current":"/es-pe/"},"displayName":"Spanish Castilian - Peru","shortUrl":"https://bit.ly/43tj13h","_type":"Locale","languageCode":"es","regionCode":"PE","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_updatedAt":"2024-07-09T11:05:00Z","nativeName":"español"},{"languageCode":"ru","_id":"hOy10qbiXBGAt5MTQoAG7t","_updatedAt":"2024-07-09T11:05:02Z","nativeName":"русский","displayName":"Russian - Russian Federation","_rev":"08sdc3VS02r1AeJ6JPOuef","localeCode":"ru-RU","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/ru-ru/"},"shortUrl":"https://bit.ly/3vkDDOu","_type":"Locale","regionCode":"RU"},{"friendlyUrl":{"current":"/pt-br/"},"displayName":"Portuguese - Brazil","_type":"Locale","languageCode":"pt","regionCode":"BR","localeCode":"pt-BR","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAFnR","nativeName":"português","shortUrl":"https://bit.ly/3UF9Msp","_rev":"iwSJAlC9N7TuVxGxCvfC6c","_updatedAt":"2024-07-09T11:05:04Z"},{"nativeName":"bosanski","shortUrl":"https://bit.ly/3VuXPYC","_type":"Locale","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoACFa","friendlyUrl":{"current":"/bs-ba/"},"_updatedAt":"2024-07-09T11:05:05Z","displayName":"Bosnian","_rev":"08sdc3VS02r1AeJ6JPP8vp","languageCode":"bs","regionCode":"Latn","localeCode":"bs-Latn-BA"},{"_createdAt":"2024-07-09T11:03:36Z","_updatedAt":"2024-07-09T11:05:07Z","displayName":"Slovenian - Slovenia","shortUrl":"https://bit.ly/3IMteyd","localeCode":"sl-SI","languageCode":"sl","regionCode":"SI","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGI7","friendlyUrl":{"current":"/sl-si/"},"nativeName":"slovenščina","_rev":"08sdc3VS02r1AeJ6JPPNrd","_type":"Locale"},{"nativeName":"Deutsch","_rev":"iwSJAlC9N7TuVxGxCvgAN4","_type":"Locale","regionCode":"CH","localeCode":"de-CH","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"friendlyUrl":{"current":"/de-ch/"},"displayName":"German - Switzerland","shortUrl":"https://bit.ly/3IRuy2E","languageCode":"de","_id":"hOy10qbiXBGAt5MTQoACa2","_updatedAt":"2024-07-09T11:05:08Z"},{"_rev":"hOy10qbiXBGAt5MTQoEBtd","_type":"Locale","languageCode":"th","friendlyUrl":{"current":"/th-th/"},"_updatedAt":"2024-07-09T11:05:10Z","nativeName":"ไทย","shortUrl":"https://bit.ly/3IOv8hY","regionCode":"TH","localeCode":"th-TH","_createdAt":"2024-07-09T11:03:36Z","isEnabled":true,"_id":"hOy10qbiXBGAt5MTQoAGXS","displayName":"Thai - Thailand"},{"_type":"Locale","languageCode":"zh","regionCode":"TW","localeCode":"zh-TW","_createdAt":"2024-07-09T11:03:36Z","_id":"hOy10qbiXBGAt5MTQoAH28","displayName":"Chinese - Taiwan, Province of China","_rev":"iwSJAlC9N7TuVxGxCvgeZu","friendlyUrl":{"current":"/zh-tw/"},"isEnabled":true,"_updatedAt":"2024-07-09T11:05:12Z","nativeName":"中文(繁體) 舊版","shortUrl":"https://bit.ly/43qqNuM"}],"_createdAt":"2023-01-19T12:09:34Z","oneTrustScriptAttributesCN":{"autoBlockSrc":"https://cdn.cookielaw.org/consent/cc1a26ec-1a2e-4023-9f59-c5ce6fa4a2e0/OtAutoBlock.js","src":"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js","_type":"oneTrustScriptAttributes","id":"cc1a26ec-1a2e-4023-9f59-c5ce6fa4a2e0"},"_type":"globalSiteSettingsPage","title":"Global Site Settings","_updatedAt":"2024-07-09T11:03:40Z","_rev":"iwSJAlC9N7TuVxGxCvb6zW","externalLinkDisclaimerBlock":{"_type":"externalLinkDisclaimerBlock","displayOption":""},"redirectManager":null},"withStackbit":false,"redesignLocales":[{"isEnabled":true,"localeCode":"en","displayName":"Global English","friendlyUrl":{"current":"en/","_type":"slug"}},{"isEnabled":true,"localeCode":"ja","displayName":"Global Japanese","friendlyUrl":{"current":"jp/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-PH","displayName":"Philippines","friendlyUrl":{"current":"/en-ph/","_type":"slug"}},{"isEnabled":true,"localeCode":"fi-FI","displayName":"Finland","friendlyUrl":{"current":"/fi-fi/","_type":"slug"}},{"isEnabled":true,"localeCode":"ar-SA","displayName":"Saudi Arabia","friendlyUrl":{"current":"ar-sa/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-SG","displayName":"Singapore","friendlyUrl":{"current":"/en-sg/","_type":"slug"}},{"isEnabled":true,"localeCode":"es-ES","displayName":"España","friendlyUrl":{"current":"/es-es/","_type":"slug"}},{"isEnabled":true,"localeCode":"es-CL","displayName":"Chile","friendlyUrl":{"current":"es-cl/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-CL","displayName":"Chile","friendlyUrl":{"current":"en-cl/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-AU","displayName":"Australia","friendlyUrl":{"current":"/en-au/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-NZ","displayName":"New Zealand","friendlyUrl":{"current":"/en-nz/","_type":"slug"}},{"isEnabled":true,"localeCode":"da-DK","displayName":"Denmark","friendlyUrl":{"current":"/da-dk/","_type":"slug"}},{"isEnabled":true,"localeCode":"sv-SE","displayName":"Sweden","friendlyUrl":{"current":"/sv-se/","_type":"slug"}},{"isEnabled":true,"localeCode":"kk-KZ","displayName":"Kazakhstan","friendlyUrl":{"_type":"slug","current":"kk-kz/"}},{"isEnabled":true,"localeCode":"id-ID","displayName":"Indonesia","friendlyUrl":{"current":"id-id/","_type":"slug"}},{"isEnabled":true,"localeCode":"no-NO","displayName":"Norway","friendlyUrl":{"_type":"slug","current":"no-no/"}},{"isEnabled":true,"localeCode":"it-IT","displayName":"Italy","friendlyUrl":{"current":"/it-it/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-SA","displayName":"Saudi Arabia","friendlyUrl":{"current":"en-sa/","_type":"slug"}},{"isEnabled":true,"localeCode":"vi-VN","displayName":"Vietnam","friendlyUrl":{"current":"vi-vn/","_type":"slug"}},{"isEnabled":true,"localeCode":"hr-HR","displayName":"Croatia","friendlyUrl":{"current":"/hr-hr/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-MY","displayName":"Malaysia","friendlyUrl":{"current":"/en-my/","_type":"slug"}},{"isEnabled":true,"localeCode":"pt-PT","displayName":"Portugal","friendlyUrl":{"current":"/pt-pt/","_type":"slug"}},{"isEnabled":true,"localeCode":"ru-KZ","displayName":"Kazakhstan","friendlyUrl":{"current":"ru-kz/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-BE","displayName":"Belgium","friendlyUrl":{"current":"/en-be/","_type":"slug"}},{"isEnabled":true,"localeCode":"es-AR","displayName":"Argentina","friendlyUrl":{"current":"/es-ar/","_type":"slug"}},{"isEnabled":true,"localeCode":"bg-BG","displayName":"Bulgaria","friendlyUrl":{"current":"/bg-bg/","_type":"slug"}},{"isEnabled":true,"localeCode":"sr-RS","displayName":"Serbia","friendlyUrl":{"current":"/sr-rs/","_type":"slug"}},{"isEnabled":true,"localeCode":"en-ZA","displayName":"South Africa","friendlyUrl":{"current":"/en-za/","_type":"slug"}},{"isEnabled":true,"localeCode":"pl-PL","displayName":"Poland","friendlyUrl":{"current":"/pl-pl/","_type":"slug"}},{"isEnabled":true,"localeCode":"ro-RO","displayName":"Romania","friendlyUrl":{"current":"ro-ro/","_type":"slug"}},{"isEnabled":true,"localeCode":"ms-MY","displayName":"Malaysia","friendlyUrl":{"current":"/ms-my/","_type":"slug"}},{"isEnabled":true,"localeCode":"es-CO","displayName":"Colombia","friendlyUrl":{"current":"/es-co/","_type":"slug"}}],"defaultLocale":{"isEnabled":true,"localeCode":"en","displayName":"Global English","friendlyUrl":{"current":"en/","_type":"slug"}}},"__N_SSG":true},"page":"/[[...slug]]","query":{"slug":["nieuws","Persberichten","2023","takeda-lanceert-nieuwe-podcastserie-Onderweg-naar-zorgen"]},"buildId":"zTwz2j3Sr5CveeDff3VTG","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[20777,3492,12062,62516,23896,67597,29391,97322],"gsp":true,"locale":"nl-nl","locales":["en","uk-ua","lt-lt","en-be","en-us","es-mx","kk-kz","el-gr","sv-se","de-at","uz-uz","en-ca","et-ee","hu-hu","fr-ch","he-il","sr-rs","en-ie","zh-hk","en-in","en-au","ko-kr","ja-jp","hr-hr","es-ve","sk-sk","id-id","pl-pl","en-vi","es-es","en-hk","bg-bg","ro-ro","ru-kz","fi-fi","zh-cn","cs-cz","fr-fr","da-dk","fr-ca","nn-no","pt-pt","es-ar","de-de","es-co","nl-nl","en-my","tr-tr","jp","es-ec","it-it","en-gb","lv-lv","es-pe","ru-ru","pt-br","bs-ba","sl-si","de-ch","th-th","zh-tw"],"defaultLocale":"en","domainLocales":[{"domain":"www.takeda.com.cn","defaultLocale":"zh-cn"}],"scriptLoader":[]}</script></body></html>